###begin article-title 0
###xml 0 20 0 20 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pneumocystis murina </italic>
###xml 0 19 <span type="species:ncbi:263815">Pneumocystis murina</span>
###xml 83 87 <span type="species:ncbi:10090">mice</span>
Pneumocystis murina colonization in immunocompetent surfactant protein A deficient mice following environmental exposure
###end article-title 0
###begin p 1
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
###end p 1
###begin title 2
Background
###end title 2
###begin p 3
###xml 0 16 0 16 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pneumocystis spp</italic>
###xml 108 121 108 121 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pneumocystis </italic>
###xml 331 343 331 343 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pneumocystis</italic>
###xml 88 94 <span type="species:ncbi:9606">humans</span>
Pneumocystis spp. are opportunistic pathogens that cause pneumonia in immunocompromised humans and animals. Pneumocystis colonization has also been detected in immunocompetent hosts and may exacerbate other pulmonary diseases. Surfactant protein A (SP-A) is an innate host defense molecule and plays a role in the host response to Pneumocystis.
###end p 3
###begin title 4
Methods
###end title 4
###begin p 5
###xml 72 85 72 85 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pneumocystis </italic>
###xml 192 202 192 202 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. murina </italic>
###xml 137 141 <span type="species:ncbi:10090">mice</span>
###xml 184 188 <span type="species:ncbi:10090">mice</span>
###xml 192 201 <span type="species:ncbi:263815">P. murina</span>
To analyze the role of SP-A in protecting the immunocompetent host from Pneumocystis colonization, the susceptibility of immunocompetent mice deficient in SP-A (KO) and wild-type (WT) mice to P. murina colonization was analyzed by reverse-transcriptase quantitative PCR (qPCR) and serum antibodies were measured by enzyme-linked immunosorbent assay (ELISA).
###end p 5
###begin title 6
Results
###end title 6
###begin p 7
###xml 13 23 13 23 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. murina </italic>
###xml 143 153 143 153 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. murina </italic>
###xml 193 200 193 200 <italic xmlns:xlink="http://www.w3.org/1999/xlink">murina </italic>
###xml 417 427 417 427 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. murina </italic>
###xml 474 484 474 484 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. murina </italic>
###xml 505 510 505 510 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SCID </italic>
###xml 13 22 <span type="species:ncbi:263815">P. murina</span>
###xml 78 82 <span type="species:ncbi:10090">mice</span>
###xml 118 122 <span type="species:ncbi:10090">mice</span>
###xml 143 152 <span type="species:ncbi:263815">P. murina</span>
###xml 190 199 <span type="species:ncbi:263815">P. murina</span>
###xml 254 258 <span type="species:ncbi:10090">mice</span>
###xml 389 393 <span type="species:ncbi:10090">mice</span>
###xml 417 426 <span type="species:ncbi:263815">P. murina</span>
###xml 468 472 <span type="species:ncbi:10090">mice</span>
###xml 474 483 <span type="species:ncbi:263815">P. murina</span>
###xml 510 514 <span type="species:ncbi:10090">mice</span>
###xml 543 547 <span type="species:ncbi:10090">mice</span>
###xml 591 595 <span type="species:ncbi:10090">mice</span>
###xml 657 661 <span type="species:ncbi:10090">mice</span>
###xml 840 844 <span type="species:ncbi:10090">mice</span>
###xml 858 862 <span type="species:ncbi:10090">mice</span>
###xml 891 895 <span type="species:ncbi:10090">mice</span>
Detection of P. murina specific serum antibodies in immunocompetent WT and KO mice indicated that the both strains of mice had been exposed to P. murina within the animal facility. However, P. murina mRNA was only detected by qPCR in the lungs of the KO mice. The incidence and level of the mRNA expression peaked at 8-10 weeks and declined to undetectable levels by 16-18 weeks. When the mice were immunosuppressed, P. murina cyst forms were also only detected in KO mice. P. murina mRNA was detected in SCID mice that had been exposed to KO mice, demonstrating that the immunocompetent KO mice are capable of transmitting the infection to immunodeficient mice. The pulmonary cellular response appeared to be responsible for the clearance of the colonization. More CD4+ and CD8+ T-cells were recovered from the lungs of immunocompetent KO mice than from WT mice, and the colonization in KO mice depleted CD4+ cells was not cleared.
###end p 7
###begin title 8
Conclusion
###end title 8
###begin p 9
###xml 90 100 90 100 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. murina </italic>
###xml 143 156 143 156 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pneumocystis </italic>
###xml 294 304 294 304 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. murina </italic>
###xml 90 99 <span type="species:ncbi:263815">P. murina</span>
###xml 208 214 <span type="species:ncbi:9606">humans</span>
###xml 272 276 <span type="species:ncbi:10090">mice</span>
###xml 294 303 <span type="species:ncbi:263815">P. murina</span>
These data support an important role for SP-A in protecting the immunocompetent host from P. murina colonization, and provide a model to study Pneumocystis colonization acquired via environmental exposure in humans. The results also illustrate the difficulties in keeping mice from exposure to P. murina even when housed under barrier conditions.
###end p 9
###begin title 10
Background
###end title 10
###begin p 11
###xml 0 16 0 16 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pneumocystis spp</italic>
###xml 146 162 146 162 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pneumocystis spp</italic>
###xml 241 242 241 242 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 256 269 256 269 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. jirovecii </italic>
###xml 392 405 392 405 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pneumocystis </italic>
###xml 477 478 477 478 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B2">2</xref>
###xml 495 508 495 508 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pneumocystis </italic>
###xml 615 628 615 628 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. jirovecii </italic>
###xml 705 706 705 706 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B3">3</xref>
###xml 707 708 707 708 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B4">4</xref>
###xml 789 802 789 802 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pneumocystis </italic>
###xml 879 880 879 880 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B5">5</xref>
###xml 881 882 881 882 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
###xml 885 898 885 898 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. jirovecii </italic>
###xml 1050 1052 1050 1052 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B10">10</xref>
###xml 1053 1055 1053 1055 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 1071 1081 1071 1081 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. murina </italic>
###xml 1282 1283 1282 1283 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B5">5</xref>
###xml 1284 1286 1284 1286 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
###xml 1453 1464 1453 1464 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. carinii </italic>
###xml 1486 1499 1486 1499 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pneumocystis </italic>
###xml 1638 1640 1638 1640 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B10">10</xref>
###xml 1764 1777 1764 1777 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. jirovecii </italic>
###xml 1791 1792 1791 1792 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 84 87 <span type="species:ncbi:9606">man</span>
###xml 248 254 <span type="species:ncbi:9606">humans</span>
###xml 256 268 <span type="species:ncbi:42068">P. jirovecii</span>
###xml 326 334 <span type="species:ncbi:9606">patients</span>
###xml 369 377 <span type="species:ncbi:9606">patients</span>
###xml 521 527 <span type="species:ncbi:9606">humans</span>
###xml 587 594 <span type="species:ncbi:9606">persons</span>
###xml 615 627 <span type="species:ncbi:42068">P. jirovecii</span>
###xml 729 734 <span type="species:ncbi:9606">human</span>
###xml 885 897 <span type="species:ncbi:42068">P. jirovecii</span>
###xml 1071 1080 <span type="species:ncbi:263815">P. murina</span>
###xml 1119 1124 <span type="species:ncbi:10090">mouse</span>
###xml 1251 1255 <span type="species:ncbi:10090">mice</span>
###xml 1377 1392 <span type="species:ncbi:10116">laboratory rats</span>
###xml 1443 1447 <span type="species:ncbi:10116">rats</span>
###xml 1453 1463 <span type="species:ncbi:4754">P. carinii</span>
###xml 1540 1569 <span type="species:ncbi:11723">simian immunodeficiency virus</span>
###xml 1596 1601 <span type="species:ncbi:9606">human</span>
###xml 1646 1652 <span type="species:ncbi:9606">humans</span>
###xml 1764 1776 <span type="species:ncbi:42068">P. jirovecii</span>
Pneumocystis spp. are ubiquitous fungal opportunistic pulmonary pathogens found, in man as well as in wild, domesticated, and laboratory animals. Pneumocystis spp. are host specific and cross infection between hosts has not been identified [1]. In humans, P. jirovecii is a significant cause of pneumonia in immunocompromised patients and despite effective treatments, patients with advanced Pneumocystis pneumonia (PcP) have poor outcomes with mortality rates as high as 50% [2]. The source of Pneumocystis infection in humans and animals remains unknown, but it has been proposed that persons with colonized with P. jirovecii may act as a reservoir of infection and as a source of infectious organisms [3,4]. Results from both human and animal studies demonstrate that colonization with Pneumocystis is not a rare event and may lead to worsening of other pulmonary conditions [5-9]. P. jirovecii colonization has been associated with increasing the severity of other pulmonary conditions such as chronic obstructive disease and chronic bronchitis [10-13]. Instances of P. murina colonization in commercial laboratory mouse colonies have been associated with various defects in the host immune response; however, under experimental conditions normal mice may also become infected [5,14]. A high incidence of colonization has been described in numerous strains and colonies of laboratory rats, but no specific risk factors for colonization of rats with P. carinii have been identified. Pneumocystis colonization has also been reported in a simian immunodeficiency virus infected macaque model of human acquired immunodeficiency syndrome [10]. In humans, cigarette smoking and certain locations of residence demonstrate a positive correlation with the incidence of P. jirovecii colonization [7].
###end p 11
###begin p 12
###xml 108 110 108 110 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 261 263 261 263 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 420 422 420 422 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 758 760 758 760 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B18">18</xref>
###xml 761 763 761 763 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 904 906 904 906 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
###xml 907 909 907 909 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B22">22</xref>
###xml 969 971 969 971 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B23">23</xref>
###xml 181 185 <span type="species:ncbi:10090">mice</span>
###xml 278 282 <span type="species:ncbi:10090">mice</span>
SP-A is a member of the collectin family of proteins and a component of the pulmonary innate immune system [15]. It is the most abundant surfactant protein, but SP-A deficient (KO) mice do not display any obvious pulmonary deficiencies under normal conditions [16]. However, KO mice are more susceptible to infection by a variety of pulmonary pathogens and mount hyperinflammatory responses to some of these infections [17]. The antimicrobial properties of SP-A act through several mechanisms that lead to enhanced clearance of pathogens from the lung. Opsonization by SP-A through interaction of its carbohydrate recognition domain with carbohydrates on the surface of pathogens increases the attachment and uptake of the organisms by alveolar macrophages [18,19]. SP-A increases the microbiocidal actions of macrophages through induction of reactive oxygen-nitrogen species and stimulating chemotaxis [20-22]. SP-A also appears to have a direct microbiocidal effect [23]. Binding of SP-A to the surface of some pathogens results in killing that is caused by permeabilization of the cell membranes or walls of the organisms.
###end p 12
###begin p 13
###xml 67 77 67 77 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. murina </italic>
###xml 101 103 101 103 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B24">24</xref>
###xml 104 106 104 106 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B25">25</xref>
###xml 259 261 259 261 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B26">26</xref>
###xml 332 342 332 342 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. murina </italic>
###xml 404 414 404 414 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. murina </italic>
###xml 461 471 461 471 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. murina </italic>
###xml 551 553 551 553 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B24">24</xref>
###xml 554 556 554 556 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B26">26</xref>
###xml 40 44 <span type="species:ncbi:10090">mice</span>
###xml 67 76 <span type="species:ncbi:263815">P. murina</span>
###xml 95 99 <span type="species:ncbi:10090">mice</span>
###xml 153 157 <span type="species:ncbi:10090">mice</span>
###xml 253 257 <span type="species:ncbi:10090">mice</span>
###xml 332 341 <span type="species:ncbi:263815">P. murina</span>
###xml 404 413 <span type="species:ncbi:263815">P. murina</span>
###xml 417 422 <span type="species:ncbi:10090">mouse</span>
###xml 451 455 <span type="species:ncbi:10090">mice</span>
###xml 461 470 <span type="species:ncbi:263815">P. murina</span>
###xml 545 549 <span type="species:ncbi:10090">mice</span>
Corticosteroid immunosuppressed SP-A KO mice develop higher levels P. murina infection than WT mice [24,25]. Immunocompetent and CD4+ T-cell depleted KO mice also display delayed clearance following infection by intratracheal inoculation compared to WT mice [26]. SP-A appears to act directly and indirectly in the host response to P. murina infection; opsonization with SP-A enhances the recognition of P. murina by mouse alveolar macrophages and KO mice with P. murina infection display a more exuberant inflammatory response than infected WT mice [24,26].
###end p 13
###begin p 14
###xml 85 95 85 95 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. murina </italic>
###xml 219 229 219 229 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. murina </italic>
###xml 484 494 484 494 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. murina </italic>
###xml 663 673 663 673 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. murina </italic>
###xml 1067 1080 1067 1080 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pneumocystis </italic>
###xml 85 94 <span type="species:ncbi:263815">P. murina</span>
###xml 127 131 <span type="species:ncbi:10090">mice</span>
###xml 219 228 <span type="species:ncbi:263815">P. murina</span>
###xml 304 308 <span type="species:ncbi:10090">mice</span>
###xml 444 448 <span type="species:ncbi:10090">mice</span>
###xml 484 493 <span type="species:ncbi:263815">P. murina</span>
###xml 637 641 <span type="species:ncbi:10090">mice</span>
###xml 663 672 <span type="species:ncbi:263815">P. murina</span>
###xml 841 847 <span type="species:ncbi:9606">humans</span>
The purpose of this study was to demonstrate that SP-A prevents the development of a P. murina colonization in immunocompetent mice following exposure to an environmental source of the organism. In most animal studies, P. murina infection is established by a rather intense exposure, i.e., housing naive mice with animals that have PcP, or by intratracheal or intranasal inoculation of a fixed dose of organisms. By contrast, in this study the mice were not experimentally exposed to P. murina but acquired the infection through environmental exposure. Environmental exposure involves a non experimental route of infection, in which the mice come in contact with P. murina during standard laboratory animal handling and housing conditions. The advantage of this model is that it more closely resembles the natural course of the infection in humans than animal models that involve exposure to large numbers of organisms. Experiments were designed to test the hypothesis that SP-A acts as an innate immune surveillance molecule protecting the immunocompetent host from Pneumocystis colonization.
###end p 14
###begin title 15
Materials and methods
###end title 15
###begin title 16
###xml 37 41 <span type="species:ncbi:10090">mice</span>
###xml 43 45 <span type="species:ncbi:10090">KO</span>
Generation of C3H/HeN SP-A deficient mice (KO)
###end title 16
###begin p 17
###xml 95 97 95 97 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B27">27</xref>
###xml 301 303 301 303 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 304 306 304 306 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B28">28</xref>
###xml 550 552 550 552 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B27">27</xref>
###xml 17 19 <span type="species:ncbi:10090">KO</span>
###xml 20 24 <span type="species:ncbi:10090">mice</span>
###xml 136 140 <span type="species:ncbi:10090">mice</span>
###xml 314 316 <span type="species:ncbi:10090">KO</span>
###xml 317 321 <span type="species:ncbi:10090">mice</span>
Black Swiss SP-A KO mice were generated by targeted gene inactivation as previously described [27]. The SP-A null allele of Black Swiss mice was bred into the C3H/HeN background through nine generations using a PCR-based genotyping strategy to track the neomycin locus of the gene-targeting cassette [16,28]. SP-A KO mice lacked detectable SP-A mRNA or protein and were deficient in tubular myelin. No alteration in the other surfactant proteins, SP-B, SP-C or SP-D, or surfactant phospholipid composition was noted in the animals deficient in SP-A [27].
###end p 17
###begin title 18
Animals
###end title 18
###begin p 19
###xml 80 84 80 84 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SCID</italic>
###xml 19 21 <span type="species:ncbi:10090">KO</span>
###xml 29 33 <span type="species:ncbi:10090">mice</span>
###xml 86 90 <span type="species:ncbi:10090">mice</span>
###xml 214 218 <span type="species:ncbi:10090">Mice</span>
###xml 489 493 <span type="species:ncbi:10090">mice</span>
###xml 550 555 <span type="species:ncbi:10090">mouse</span>
###xml 686 690 <span type="species:ncbi:10090">mice</span>
All of the C3H/HeN KO and WT mice and C3H/HeN severe combined immunodeficiency (SCID) mice used in these studies were bred and housed at the University of Cincinnati (UC) Laboratory Animal Medicine (LAM) facility. Mice used in these studies were housed in a single room within the LAM facility under barrier conditions: in microisolator cages; with autoclaved food and water; and restricted access of personnel. The cages are changed in a biocontainment hood, 2-3 times per week. Sentinel mice from the animal room are tested for a standard panel of mouse pathogens on a quarterly and semi annual basis. Over the past 5 years, none of these pathogens have been detected in the sentinel mice from the animal room used for these studies. All animal studies conformed to NIH, UC, and the Department of Veterans Affairs guidelines.
###end p 19
###begin title 20
Corticosteroid Immunosuppression Regimen
###end title 20
###begin p 21
###xml 0 4 <span type="species:ncbi:10090">Mice</span>
Mice were immunosuppressed by the addition of dexamethasone (4 mg/l) in their drinking water. Ampicillin (0.5 mg/ml) was added to the drinking water to prevent development of secondary bacterial infection.
###end p 21
###begin title 22
Antibody mediated CD4+T cell depletion
###end title 22
###begin p 23
###xml 122 124 122 124 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B29">29</xref>
###xml 0 4 <span type="species:ncbi:10090">Mice</span>
Mice were injected i.p. with 100 ug of GK1.5 antibody 3 times 2 days apart for one week and then once a week for 3 weeks [29].
###end p 23
###begin title 24
Transmission of Infection by Direct Exposure ("seeding")
###end title 24
###begin p 25
###xml 51 61 51 61 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. murina </italic>
###xml 107 117 107 117 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. murina </italic>
###xml 155 160 155 160 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SCID </italic>
###xml 197 202 197 202 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SCID </italic>
###xml 418 420 418 420 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B30">30</xref>
###xml 20 22 <span type="species:ncbi:10090">KO</span>
###xml 23 28 <span type="species:ncbi:10090">mouse</span>
###xml 51 60 <span type="species:ncbi:263815">P. murina</span>
###xml 83 85 <span type="species:ncbi:10090">KO</span>
###xml 86 91 <span type="species:ncbi:10090">mouse</span>
###xml 107 116 <span type="species:ncbi:263815">P. murina</span>
###xml 160 164 <span type="species:ncbi:10090">mice</span>
###xml 202 206 <span type="species:ncbi:10090">mice</span>
###xml 227 229 <span type="species:ncbi:10090">KO</span>
###xml 230 234 <span type="species:ncbi:10090">mice</span>
###xml 385 389 <span type="species:ncbi:10090">mice</span>
An immunosuppressed KO mouse heavily infected with P. murina or an immunocompetent KO mouse colonized with P. murina were housed in the same cage with six SCID mice for two weeks. A third group of SCID mice were not exposed to KO mice. Transmission of Pneumocystis infection by direct exposure to an animal infected with Pneumocystis has been referred to as "seeding" and the infected mice are referred to as "seeds" [30].
###end p 25
###begin title 26
###xml 15 25 15 25 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. murina </italic>
###xml 15 24 <span type="species:ncbi:263815">P. murina</span>
Infection with P. murina by intratracheal inoculation
###end title 26
###begin p 27
###xml 0 10 0 10 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. murina </italic>
###xml 78 80 78 80 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B31">31</xref>
###xml 124 126 124 126 <sup xmlns:xlink="http://www.w3.org/1999/xlink">6 </sup>
###xml 126 136 126 136 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. murina </italic>
###xml 0 9 <span type="species:ncbi:263815">P. murina</span>
###xml 87 91 <span type="species:ncbi:10090">mice</span>
###xml 126 135 <span type="species:ncbi:263815">P. murina</span>
P. murina was isolated and processed for inoculation as previously described [31]. The mice were lightly anesthetized and 106 P. murina cyst forms were introduced into the lung through a tube inserted into the trachea.
###end p 27
###begin title 28
###xml 62 72 62 72 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. murina </italic>
###xml 62 71 <span type="species:ncbi:263815">P. murina</span>
Reverse-transcriptase quantitative PCR (qPCR) quantitation of P. murina infection levels
###end title 28
###begin p 29
###xml 19 27 19 27 <italic xmlns:xlink="http://www.w3.org/1999/xlink">en bloc </italic>
###xml 137 139 131 133 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B25">25</xref>
###xml 219 223 213 215 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#174; </sup>
###xml 674 684 647 657 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. murina </italic>
###xml 877 879 850 852 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B32">32</xref>
###xml 1100 1110 1073 1083 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. murina </italic>
###xml 1190 1192 1163 1165 <sup xmlns:xlink="http://www.w3.org/1999/xlink">7 </sup>
###xml 1192 1202 1165 1175 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. murina </italic>
###xml 1388 1398 1361 1371 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. murina </italic>
###xml 1486 1488 1459 1461 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B33">33</xref>
###xml 674 683 <span type="species:ncbi:263815">P. murina</span>
###xml 1100 1109 <span type="species:ncbi:263815">P. murina</span>
###xml 1192 1201 <span type="species:ncbi:263815">P. murina</span>
###xml 1388 1397 <span type="species:ncbi:263815">P. murina</span>
Lungs were removed en bloc flash frozen in liquid nitrogen, ground into a fine powder and stored at -70degreesC for subsequent analyses [25]. Approximately 50 mgs of frozen lung tissue was reconstituted in 1.0 ml Trizol(R) Reagent (Invitrogen, Carlsbad, CA) and total RNA was isolated. The RNA was treated with RNAase free-DNAase and recovered by phenol:chloroform extraction and ethanol precipitation. The RNA was evaluated in a spectrophotometer at 260 lambda and 280 lambda. cDNA was made from 1 ug of RNA using the SuperScripttrade mark II RNAase H- Reverse Transcriptase (Invitrogen, Carlsbad, CA) according to the manufacturer's directions. Quantitation of the amount P. murina large subunit ribosomal RNA gene (mtLSU) message in the samples was performed on the iCycler iQ Real-Time PCR Detection System (BioRad, Hercules, CA) using a previously described TaqMan assay [32]. The threshold cycle for each sample was identified as the point at which the fluorescence generated by degradation of the TaqMan probe increased significantly above the baseline. To convert the threshold cycle data to P. murina nuclei, a standard curve was generated using cDNA made from RNA isolated from 107 P. murina nuclei. The level of infection of the samples was then estimated using the standard curve. The efficiency of the standard curve qPCR reactions consistently approached 100%. Detection of P. murina mtLSU with this assay has also been shown to correlate with viability of the organisms [33].
###end p 29
###begin p 30
###xml 147 152 <span type="species:ncbi:10090">mouse</span>
###xml 264 269 <span type="species:ncbi:10090">mouse</span>
To ensure that high quality RNA was isolated from all samples and that cDNA synthesis was successful, a SybrGreen incorporation qPCR assay for the mouse vimentin gene mRNA was performed on all samples. Primers were designed to amplify a 109 base pair product from mouse vimentin mRNA (Vimentin-Forward Primer 5'-GTGCGCCAGCAGTATGAAAG-3', Vimentin-Reverse Primer 5'-GCATCGTTGTTCCGGTTGG-3'). qPCR was performed using Taq DNA polymerase (Promega, Madison, WI), with SybrGreen (Invitrogen, Carlsbad, CA) added to the buffer, in the iCycler iQ Real-Time PCR Detection System (BioRad, Hercules, CA). The following reaction conditions were used: Cycle 1. 95degreesC for 3:00 minutes; Cycle 2. 95degreesC for15 sec, 60degreesC for 30 sec with 40 repeats. The fluorescent signal generated by incorporation of SybrGreen into the double-stranded product was collected at 86degreesC for 10 sec during each repeat to determine the threshold cycle for each sample. The fidelity of the qPCR reactions was confirmed by analysis of the melt curve of the vimentin qPCR product. A single peak with an approximate melting temperature of 88degreesC was consistently identified in the reactions. The efficiency of the vimentin qPCR reactions consistently approached 100%.
###end p 30
###begin title 31
###xml 27 36 27 36 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. murina</italic>
###xml 27 36 <span type="species:ncbi:263815">P. murina</span>
Microscopic Enumeration of P. murina
###end title 31
###begin p 32
###xml 53 63 53 63 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. murina </italic>
###xml 171 173 171 173 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
###xml 202 205 202 205 <sub xmlns:xlink="http://www.w3.org/1999/xlink">10 </sub>
###xml 250 260 250 260 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. murina </italic>
###xml 321 323 321 323 <sup xmlns:xlink="http://www.w3.org/1999/xlink">4 </sup>
###xml 53 62 <span type="species:ncbi:263815">P. murina</span>
###xml 250 259 <span type="species:ncbi:263815">P. murina</span>
###xml 348 353 <span type="species:ncbi:10090">mouse</span>
As previously described, microscopic quantitation of P. murina cyst forms and nuclei was performed following Cresyl-Echt violet (CEV) and Dif Quik staining, respectively [14]. Data were expressed as log10 cysts forms or nuclei per lung. The limit of P. murina detection by microscopic evaluation is approximately 2.5 x 104 cyst forms or nuclei per mouse.
###end p 32
###begin title 33
###xml 59 69 59 69 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. murina </italic>
###xml 59 68 <span type="species:ncbi:263815">P. murina</span>
Cloning, expression, and purification of a fragment of the P. murina MSG
###end title 33
###begin p 34
###xml 85 95 85 95 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. murina </italic>
###xml 413 423 413 423 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. murina </italic>
###xml 85 94 <span type="species:ncbi:263815">P. murina</span>
###xml 413 422 <span type="species:ncbi:263815">P. murina</span>
###xml 653 669 <span type="species:ncbi:562">Escherichia coli</span>
###xml 738 745 <span type="species:ncbi:562">E. coli</span>
###xml 1449 1455 <span type="species:ncbi:9913">bovine</span>
Oligonucleotides were designed on the basis of the known sequence of the MSG gene of P. murina and were used in polymerase chain reaction (PCR) to generate a fragment of the MSG gene spanning a nucleotides 2139-3040 corresponding to amino acids 713-1013. The sequences of the oligonucleotides were 2139-5'-GAACTCAAGGAAATTGTACGGCAG-3'-2163 and 3040-5'-TGTTCCTGGTGTTGATGGTGCT-3'-3061. Genomic DNA was purified from P. murina using the Qiagen kit and used as a template for the PCR reactions. The sequence of the PCR products was confirmed, and they were cloned into the pET30 expression vector (Novagen) in the correct reading frame and were expressed in Escherichia coli. The recombinant proteins were expressed in inclusion bodies within E. coli and were purified by standard methods. In brief, bacterial cultures expressing recombinant MSG fragments were harvested by centrifugation, the cell pellet was sonicated and washed 3 times in binding buffer without urea (5 mM imidazole, 0.5 M NaCl, and 20 mM Tris-HCl [pH 7.9]), and the final pellet was dissolved in binding buffer with 6 M urea. The recombinant preparations were purified by affinity chromatography using HISbinding resin (Novagen), with the urea being removed during the wash stages. Eluted proteins were dialyzed overnight against PBS (pH 7.4), were filter sterilized, and were frozen at -70degreesC. Protein concentration was determined by A280 using a standard curve generated with bovine serum albumin.
###end p 34
###begin title 35
###xml 12 22 12 22 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. murina </italic>
###xml 12 21 <span type="species:ncbi:263815">P. murina</span>
Analysis of P. murina specific serum antibodies by ELISA
###end title 35
###begin p 36
It is clear that different subclasses of IgG mediate diverse host defense mechanisms such as binding of IgG to the various Fc receptors on effector cells. Therefore, MSG specific IgG1, IgG2a and IgG2b were measured in this experiment. These subclasses were examined because they are considered to be more reactive with protein epitopes that would be present on the recombinant antigens, as compared to IgG3 that is recognized as being more reactive with carbohydrate epitopes.
###end p 36
###begin p 37
###xml 405 409 <span type="species:ncbi:9925">goat</span>
###xml 415 418 <span type="species:ncbi:10116">rat</span>
###xml 437 448 <span type="species:ncbi:3704">horseradish</span>
Duplicate wells of a 96-well plate were coated overnight with recombinant MSG at 4degreesC. The plates were washed with PBS-0.1% Tween-20 and then blocked with 1% BSA in PBS for 1 hour at room temperature. Following blocking, the sera were incubated in duplicate wells at a 1/100 dilution in PBS for 1 hour at room temperature. Plates were washed and incubated with a 1/1000 dilution of affinity purified goat anti-rat IgG conjugated to horseradish peroxidase (0.1 mg/ml)(Kirkegaard and Perry Laboratories, Gaithersburg, MD) for 1 hour at room temperature. Following washing, ABTS peroxidase substrate (Kirkegaard and Perry Laboratories, Gaithersburg, MD) was added to each well and development was monitored by determining the optical density (OD) at 405 nm in an ELISA reader.
###end p 37
###begin title 38
Isolation and Analysis of Pulmonary CD4+ and CD8+ T cells
###end title 38
###begin p 39
###xml 76 78 76 78 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B34">34</xref>
###xml 307 311 298 300 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#174; </sup>
###xml 420 422 409 411 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B35">35</xref>
###xml 484 489 <span type="species:ncbi:10090">Mouse</span>
###xml 533 536 <span type="species:ncbi:10116">rat</span>
###xml 542 547 <span type="species:ncbi:10090">mouse</span>
###xml 599 602 <span type="species:ncbi:10116">rat</span>
###xml 608 613 <span type="species:ncbi:10090">mouse</span>
Cells were isolated and quantitated from the lungs as previously described [34]. Briefly, lungs were removed and ground between two frosted glass slides in PBS with 1% BSA and mononuclear cells were isolated from the homogenate on 40 to 70% Percoll gradients and enumerated on a Z2trade mark Coulter Counter(R) (Beckman Coulter, Hialeah, FL). Labeling and flow cytometry analysis were performed as previously described [35]. The cells were labeled with an APC-conjugated Hamster anti-Mouse CD3 monoclonal antibody, a FITC-conjugated rat anti-mouse CD4(L3T4) monoclonal antibody, and a PE-conjugated rat anti-mouse CD4 (Ly-2) monoclonal antibody. All antibodies were obtained from BD Biosciences Pharmingen (San Diego, CA). Cells were analyzed on a FACSCaliburtrade mark Flow Cytometry System (BD Biosciences, San Jose, CA).
###end p 39
###begin title 40
Statistical Analysis
###end title 40
###begin p 41
Unpaired t tests were used to compare results of experiments between two groups. Multi-group comparisons between all groups in an experiment were performed by one-way analysis of variance (ANOVA) followed by the Tukey-Kramer test for multiple comparisons. All calculations were done with INSTAT (Graph Pad Software for Science, San Diego, CA). Significance was accepted when the P value was < 0.05 (2-sided).
###end p 41
###begin title 42
Results
###end title 42
###begin title 43
###xml 26 36 26 36 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. murina </italic>
###xml 26 35 <span type="species:ncbi:263815">P. murina</span>
###xml 108 110 <span type="species:ncbi:10090">KO</span>
###xml 111 115 <span type="species:ncbi:10090">mice</span>
Environmental exposure to P. murina leads to the development of a transient colonization in immunocompetent KO mice
###end title 43
###begin p 44
###xml 97 107 97 107 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. murina </italic>
###xml 125 135 125 135 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. murina </italic>
###xml 611 621 611 621 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. murina </italic>
###xml 853 854 853 854 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1</xref>
###xml 946 947 946 947 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T1">1</xref>
###xml 1447 1457 1447 1457 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. murina </italic>
###xml 1829 1839 1829 1839 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. murina </italic>
###xml 23 25 <span type="species:ncbi:10090">KO</span>
###xml 26 30 <span type="species:ncbi:10090">mice</span>
###xml 97 106 <span type="species:ncbi:263815">P. murina</span>
###xml 125 134 <span type="species:ncbi:263815">P. murina</span>
###xml 209 213 <span type="species:ncbi:10090">mice</span>
###xml 331 335 <span type="species:ncbi:10090">mice</span>
###xml 400 404 <span type="species:ncbi:10090">mice</span>
###xml 423 427 <span type="species:ncbi:10090">Mice</span>
###xml 472 476 <span type="species:ncbi:10090">mice</span>
###xml 520 524 <span type="species:ncbi:10090">mice</span>
###xml 552 556 <span type="species:ncbi:10090">mice</span>
###xml 573 577 <span type="species:ncbi:10090">mice</span>
###xml 611 620 <span type="species:ncbi:263815">P. murina</span>
###xml 663 667 <span type="species:ncbi:10090">mice</span>
###xml 683 685 <span type="species:ncbi:10090">KO</span>
###xml 686 690 <span type="species:ncbi:10090">mice</span>
###xml 767 771 <span type="species:ncbi:10090">mice</span>
###xml 827 831 <span type="species:ncbi:10090">mice</span>
###xml 875 879 <span type="species:ncbi:10090">mice</span>
###xml 1049 1053 <span type="species:ncbi:10090">mice</span>
###xml 1165 1169 <span type="species:ncbi:10090">mice</span>
###xml 1270 1274 <span type="species:ncbi:10090">mice</span>
###xml 1392 1394 <span type="species:ncbi:10090">KO</span>
###xml 1402 1406 <span type="species:ncbi:10090">mice</span>
###xml 1447 1456 <span type="species:ncbi:263815">P. murina</span>
###xml 1518 1520 <span type="species:ncbi:10090">KO</span>
###xml 1521 1525 <span type="species:ncbi:10090">mice</span>
###xml 1662 1666 <span type="species:ncbi:10090">mice</span>
###xml 1829 1838 <span type="species:ncbi:263815">P. murina</span>
###xml 1902 1904 <span type="species:ncbi:10090">KO</span>
###xml 1905 1909 <span type="species:ncbi:10090">mice</span>
Immunocompetent WT and KO mice, between the ages of 2-18 weeks, with no experimental exposure to P. murina were examined for P. murina colonization by testing for the presence of mtLSU message by RT-qPCR. All mice used in these analyses were bred and housed under identical conditions as described in the material and methods. The mice were grouped at two-week age intervals and were only caged with mice within the group. Mice within a group were housed together up to 5 mice per cage. Some cages contained less than 5 mice depending on the number of mice in a group. All mice were housed in the same room. No P. murina specific mtLSU message was detected in WT mice of any age. In KO mice, the level of detection of the mtLSU message increased over time peaking in mice 8-10 weeks of age and then declined to undetectable in mice 16-18 weeks old (Fig 1). The percentage of mice within a group with detectable mtLSU also varied over time (Table 1). The frequency of the detection peaked in the 8-10 week group when mtLSU was detected in all of the mice Vimentin was used as a housekeeping gene marker to verify that the failure to detect mtLSU message in negative mice was not due to poor quality RNA or cDNA in the samples. Vimentin message was detected in all of the mice and no significant differences in the levels of expression were evident (data not shown). Lungs from immunocompetent KO and WT mice were also evaluated for the presence of P. murina cyst forms by CEV staining. The level of colonization in the KO mice was below the limit of microscopic detection as demonstrated by the inability to detect cyst or nuclei forms in the lungs of any of the mice following CEV or DQ staining by standard enumeration techniques. In this manuscript, the term colonization will be used to describe the presence of the low-level P. murina infection that appears to transiently exist in immunocompetent KO mice.
###end p 44
###begin p 45
###xml 55 65 55 65 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. murina </italic>
###xml 112 122 112 122 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. murina </italic>
###xml 30 34 <span type="species:ncbi:10090">mice</span>
###xml 55 64 <span type="species:ncbi:263815">P. murina</span>
###xml 112 121 <span type="species:ncbi:263815">P. murina</span>
Percentages of SP-A deficient mice with colonized with P. murina as determined by quantitative PCR detection of P. murina large subunit ribosomal RNA gene transcripts.
###end p 45
###begin p 46
###xml 45 55 45 55 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. murina </italic>
###xml 0 121 0 121 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Analysis of the development and clearance of <italic>P. murina </italic>colonization in immunocompetent SP-A deficient (KO) mice over time</bold>
###xml 210 220 210 220 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. murina </italic>
###xml 288 298 288 298 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. murina </italic>
###xml 453 463 451 461 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. murina </italic>
###xml 45 54 <span type="species:ncbi:263815">P. murina</span>
###xml 103 105 <span type="species:ncbi:10090">KO</span>
###xml 107 111 <span type="species:ncbi:10090">mice</span>
###xml 139 141 <span type="species:ncbi:10090">KO</span>
###xml 142 146 <span type="species:ncbi:10090">mice</span>
###xml 210 219 <span type="species:ncbi:263815">P. murina</span>
###xml 288 297 <span type="species:ncbi:263815">P. murina</span>
###xml 453 462 <span type="species:ncbi:263815">P. murina</span>
###xml 574 578 <span type="species:ncbi:10090">mice</span>
Analysis of the development and clearance of P. murina colonization in immunocompetent SP-A deficient (KO) mice over time. Immunocompetent KO mice between 2 and 18 weeks of age with no experimental exposure to P. murina were sacrificed, RNA extracted from the lungs and cDNA synthesized. P. murina large mitochondrial ribosomal RNA gene (mtLSU) mRNA levels were quantitated in the samples by qPCR. The data are the mean +/- the SEM and are expressed as P. murina nuclei per reaction. *p < 0.05 vs. 8-10 week old group as determined by ANOVA. Each group contained at least 5 mice.
###end p 46
###begin title 47
###xml 32 42 32 42 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. murina </italic>
###xml 32 41 <span type="species:ncbi:263815">P. murina</span>
###xml 55 57 <span type="species:ncbi:10090">KO</span>
###xml 58 62 <span type="species:ncbi:10090">mice</span>
Immunosuppression induces heavy P. murina infection in KO mice following environmental exposure
###end title 47
###begin p 48
###xml 56 66 56 66 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. murina </italic>
###xml 206 216 206 216 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. murina </italic>
###xml 272 273 272 273 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2</xref>
###xml 276 286 276 286 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. murina </italic>
###xml 523 533 523 533 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. murina </italic>
###xml 15 17 <span type="species:ncbi:10090">KO</span>
###xml 18 22 <span type="species:ncbi:10090">mice</span>
###xml 56 65 <span type="species:ncbi:263815">P. murina</span>
###xml 162 166 <span type="species:ncbi:10090">mice</span>
###xml 206 215 <span type="species:ncbi:263815">P. murina</span>
###xml 276 285 <span type="species:ncbi:263815">P. murina</span>
###xml 318 320 <span type="species:ncbi:10090">KO</span>
###xml 321 325 <span type="species:ncbi:10090">mice</span>
###xml 361 365 <span type="species:ncbi:10090">mice</span>
###xml 425 427 <span type="species:ncbi:10090">KO</span>
###xml 428 432 <span type="species:ncbi:10090">mice</span>
###xml 477 479 <span type="species:ncbi:10090">KO</span>
###xml 480 484 <span type="species:ncbi:10090">mice</span>
###xml 523 532 <span type="species:ncbi:263815">P. murina</span>
C3H/HeN WT and KO mice with no experimental exposure to P. murina were immunosuppressed by the addition of dexamethasone to their drinking water for 4 weeks. The mice were sacrificed and lungs examined for P. murina infection by microscopic enumeration of cyst forms (Fig 2). P. murina infection only developed in the KO mice; no cyst forms were detected in WT mice whereas significant numbers of cyst forms were detected in KO mice. The development of active infection in the KO mice suggests that in the absence of SP-A, P. murina is able to survive in the immunocompetent host and initiate a heavy infection.
###end p 48
###begin p 49
###xml 21 31 21 31 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. murina </italic>
###xml 0 104 0 104 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Development of heavy <italic>P. murina </italic>infection in immunosuppressed Wild-Type (WT) and SP-A deficient (KO) mice</bold>
###xml 202 212 202 212 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. murina </italic>
###xml 284 294 284 294 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. murina </italic>
###xml 329 331 329 331 <sup xmlns:xlink="http://www.w3.org/1999/xlink">4 </sup>
###xml 351 354 351 354 <sub xmlns:xlink="http://www.w3.org/1999/xlink">10 </sub>
###xml 386 389 386 389 <sub xmlns:xlink="http://www.w3.org/1999/xlink">10 </sub>
###xml 21 30 <span type="species:ncbi:263815">P. murina</span>
###xml 96 98 <span type="species:ncbi:10090">KO</span>
###xml 100 104 <span type="species:ncbi:10090">mice</span>
###xml 127 129 <span type="species:ncbi:10090">KO</span>
###xml 147 151 <span type="species:ncbi:10090">mice</span>
###xml 202 211 <span type="species:ncbi:263815">P. murina</span>
###xml 284 293 <span type="species:ncbi:263815">P. murina</span>
###xml 399 404 <span type="species:ncbi:10090">mouse</span>
###xml 489 494 <span type="species:ncbi:10090">mouse</span>
Development of heavy P. murina infection in immunosuppressed Wild-Type (WT) and SP-A deficient (KO) mice. WT (open square) and KO (black triangle) mice were immunosuppressed for 4 weeks, sacrificed and P. murina cysts forms in the lungs were quantitated microscopically. The limit of P. murina detection is approximately 2.5 x 104 cyst forms/lung (log10 4.4). Data were expressed as log10 cysts per mouse. Horizontal lines indicate mean log cysts per group. Each point represents a single mouse. *p < 0.01 as determined by t test. The arrow indicates the level of detection of microscopic enumeration.
###end p 49
###begin title 50
###xml 33 43 33 43 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. murina </italic>
###xml 16 18 <span type="species:ncbi:10090">KO</span>
###xml 19 23 <span type="species:ncbi:10090">mice</span>
###xml 33 42 <span type="species:ncbi:263815">P. murina</span>
###xml 61 65 <span type="species:ncbi:10090">Mice</span>
Immunocompetent KO mice transmit P. murina infection to SCID Mice
###end title 50
###begin p 51
###xml 85 95 85 95 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. murina </italic>
###xml 112 117 112 117 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SCID </italic>
###xml 192 202 192 202 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. murina </italic>
###xml 242 251 242 251 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. murina</italic>
###xml 293 298 293 298 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SCID </italic>
###xml 62 64 <span type="species:ncbi:10090">KO</span>
###xml 65 69 <span type="species:ncbi:10090">mice</span>
###xml 85 94 <span type="species:ncbi:263815">P. murina</span>
###xml 117 121 <span type="species:ncbi:10090">mice</span>
###xml 162 164 <span type="species:ncbi:10090">KO</span>
###xml 165 169 <span type="species:ncbi:10090">mice</span>
###xml 192 201 <span type="species:ncbi:263815">P. murina</span>
###xml 221 223 <span type="species:ncbi:10090">KO</span>
###xml 224 228 <span type="species:ncbi:10090">mice</span>
###xml 242 251 <span type="species:ncbi:263815">P. murina</span>
###xml 298 302 <span type="species:ncbi:10090">mice</span>
###xml 322 324 <span type="species:ncbi:10090">KO</span>
###xml 325 329 <span type="species:ncbi:10090">mice</span>
###xml 349 353 <span type="species:ncbi:10090">mice</span>
###xml 387 392 <span type="species:ncbi:10090">mouse</span>
###xml 485 489 <span type="species:ncbi:10090">mice</span>
This experiment was conducted to determine if immunocompetent KO mice colonized with P. murina were infectious. SCID mice were exposed to either immunosuppressed KO mice heavily infected with P. murina or immunocompetent KO mice colonized by P. murina. As a negative control, a third group of SCID mice was not exposed to KO mice. A fourth group of mice exposed to an immunocompetent WT mouse was not included in the experiment due to the availability of only a limited number of SCID mice
###end p 51
###begin p 52
###xml 78 88 78 88 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. murina </italic>
###xml 116 126 116 126 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. murina </italic>
###xml 333 334 333 334 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3</xref>
###xml 637 647 637 647 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. murina </italic>
###xml 754 764 754 764 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. murina </italic>
###xml 0 4 <span type="species:ncbi:10090">Mice</span>
###xml 78 87 <span type="species:ncbi:263815">P. murina</span>
###xml 116 125 <span type="species:ncbi:263815">P. murina</span>
###xml 167 171 <span type="species:ncbi:10090">mice</span>
###xml 200 202 <span type="species:ncbi:10090">KO</span>
###xml 203 207 <span type="species:ncbi:10090">mice</span>
###xml 219 223 <span type="species:ncbi:10090">mice</span>
###xml 251 253 <span type="species:ncbi:10090">KO</span>
###xml 254 258 <span type="species:ncbi:10090">mice</span>
###xml 282 286 <span type="species:ncbi:10090">mice</span>
###xml 377 381 <span type="species:ncbi:10090">mice</span>
###xml 414 416 <span type="species:ncbi:10090">KO</span>
###xml 417 421 <span type="species:ncbi:10090">mice</span>
###xml 430 434 <span type="species:ncbi:10090">mice</span>
###xml 462 464 <span type="species:ncbi:10090">KO</span>
###xml 465 469 <span type="species:ncbi:10090">mice</span>
###xml 531 535 <span type="species:ncbi:10090">mice</span>
###xml 609 613 <span type="species:ncbi:10090">mice</span>
###xml 637 646 <span type="species:ncbi:263815">P. murina</span>
###xml 700 702 <span type="species:ncbi:10090">KO</span>
###xml 703 707 <span type="species:ncbi:10090">mice</span>
###xml 754 763 <span type="species:ncbi:263815">P. murina</span>
Mice were sacrificed two weeks post exposure and examined for the presence of P. murina mtLSU in the lungs by qPCR. P. murina mtLSU message was detected in all of the mice exposed to immunosuppressed KO mice, in 5 of 6 mice exposed to immunocompetent KO mice, but not in any of the mice in the nonexposed negative control group (Fig 3). Higher levels of mtLSU were detected in mice exposed to the immunosuppressed KO mice than in mice exposed to immunocompetent KO mice. Similar vimentin message levels were detected in all of the mice (data not shown). The results do not demonstrate that immunocompetent WT mice are unable to transmit P. murina infection, but strongly suggest that immunocompetent KO mice with colonization may serve as a reservoir of P. murina infection and are capable of transmitting the infection to immunocompromised hosts.
###end p 52
###begin p 53
###xml 16 26 16 26 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. murina </italic>
###xml 119 123 119 123 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SCID</italic>
###xml 0 129 0 129 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Transmission of <italic>P. murina </italic>infection from immunocompetent SP-A deficient (KO) mice to severe combined immunodeficiency (<italic>SCID</italic>) mice</bold>
###xml 131 136 131 136 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SCID </italic>
###xml 578 583 578 583 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SCID </italic>
###xml 656 666 656 666 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. murina </italic>
###xml 813 823 811 821 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. murina </italic>
###xml 16 25 <span type="species:ncbi:263815">P. murina</span>
###xml 73 75 <span type="species:ncbi:10090">KO</span>
###xml 77 81 <span type="species:ncbi:10090">mice</span>
###xml 125 129 <span type="species:ncbi:10090">mice</span>
###xml 136 140 <span type="species:ncbi:10090">mice</span>
###xml 268 270 <span type="species:ncbi:10090">KO</span>
###xml 276 280 <span type="species:ncbi:10090">mice</span>
###xml 318 322 <span type="species:ncbi:10090">mice</span>
###xml 346 348 <span type="species:ncbi:10090">KO</span>
###xml 349 353 <span type="species:ncbi:10090">mice</span>
###xml 541 545 <span type="species:ncbi:10090">mice</span>
###xml 583 587 <span type="species:ncbi:10090">mice</span>
###xml 656 665 <span type="species:ncbi:263815">P. murina</span>
###xml 813 822 <span type="species:ncbi:263815">P. murina</span>
###xml 919 923 <span type="species:ncbi:10090">mice</span>
Transmission of P. murina infection from immunocompetent SP-A deficient (KO) mice to severe combined immunodeficiency (SCID) mice. SCID mice were housed in the same cage with immunosuppressed (i/s) (black triangles) or immunocompetent (i/c) (inverted black triangles) KO seed mice for two weeks. A third group of SCID mice was not exposed to any KO mice as a negative control (open squares). Transmission of Pneumocystis infection by direct exposure to an animal infected with Pneumocystis has been referred to as "seeding" and the infected mice are referred to as "seeds". The SCID mice were sacrificed, RNA extracted from the lungs and cDNA synthesized. P. murina large mitochondrial ribosomal RNA gene mRNA levels were quantitated in the samples by qPCR. The data are the mean +/- the SEM and are expressed as P. murina nuclei per reaction. *p < 0.05 i/s seed vs. i/c seed by t test. Each group contained at least 5 mice.
###end p 53
###begin title 54
###xml 0 10 0 10 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. murina </italic>
###xml 0 9 <span type="species:ncbi:263815">P. murina</span>
###xml 73 75 <span type="species:ncbi:10090">KO</span>
###xml 83 87 <span type="species:ncbi:10090">mice</span>
P. murina MSG specific serum antibodies detected in both immunocompetent KO and WT mice
###end title 54
###begin p 55
###xml 346 356 346 356 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. murina </italic>
###xml 449 459 449 459 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. murina </italic>
###xml 521 531 521 531 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. murina </italic>
###xml 111 113 <span type="species:ncbi:10090">KO</span>
###xml 121 125 <span type="species:ncbi:10090">mice</span>
###xml 206 210 <span type="species:ncbi:10090">mice</span>
###xml 346 355 <span type="species:ncbi:263815">P. murina</span>
###xml 398 403 <span type="species:ncbi:10090">mouse</span>
###xml 449 458 <span type="species:ncbi:263815">P. murina</span>
###xml 521 530 <span type="species:ncbi:263815">P. murina</span>
To further examine the development of the humoral response, serial serum samples were obtained from individual KO and WT mice by retro orbital eye bleed at 4, 6, and 8 weeks of age. At 10 weeks of age, the mice were sacrificed and a terminal blood sample was collected by cardiac puncture. This procedure allowed us to monitor the development of P. murina specific antibodies over time in the same mouse. The samples were tested for the presence of P. murina specific antibodies by ELISA, using a recombinant fragment of P. murina MSG spanning amino acids 336-437.
###end p 55
###begin p 56
###xml 167 169 167 169 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4A</xref>
###xml 367 369 367 369 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4B</xref>
###xml 434 436 434 436 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4C</xref>
###xml 561 566 561 566 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4A, B</xref>
###xml 571 573 571 573 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4C</xref>
###xml 662 671 662 671 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. murina</italic>
###xml 75 77 <span type="species:ncbi:10090">KO</span>
###xml 78 82 <span type="species:ncbi:10090">mice</span>
###xml 271 273 <span type="species:ncbi:10090">KO</span>
###xml 274 278 <span type="species:ncbi:10090">mice</span>
###xml 288 292 <span type="species:ncbi:10090">mice</span>
###xml 297 301 <span type="species:ncbi:10090">mice</span>
###xml 335 337 <span type="species:ncbi:10090">KO</span>
###xml 338 342 <span type="species:ncbi:10090">mice</span>
###xml 424 428 <span type="species:ncbi:10090">mice</span>
###xml 528 532 <span type="species:ncbi:10090">mice</span>
###xml 548 550 <span type="species:ncbi:10090">KO</span>
###xml 551 555 <span type="species:ncbi:10090">mice</span>
###xml 619 621 <span type="species:ncbi:10090">KO</span>
###xml 622 626 <span type="species:ncbi:10090">mice</span>
###xml 662 671 <span type="species:ncbi:263815">P. murina</span>
###xml 749 753 <span type="species:ncbi:10090">mice</span>
MSG-specific IgG1 antibodies levels increased over time in both the WT and KO mice and no significant differences were detected between the two groups at any age (Fig 4A). Significant differences in the levels of MSG specific IgG2a and IgG2b were detected between WT and KO mice in older mice. WT mice had more MSG-specific IgG2a than KO mice at 10 weeks of age (Fig 4B) and IgG2b levels were higher in 8 and 10 week old WT mice (Fig 4C). IgG2a and IgG2b MSG-specific antibodies also increased significantly over time in the WT mice but not in the KO mice (Fig 4A, B and 4C). These results demonstrate that both WT and KO mice mount a humoral immune response to P. murina. However, it is not clear if the antibodies play a role in protecting the WT mice from colonization.
###end p 56
###begin p 57
###xml 16 26 16 26 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. murina </italic>
###xml 0 112 0 112 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Analysis of the <italic>P. murina </italic>serum antibody response in immunocompetent Wild-Type (WT) and SP-A deficient (KO) mice</bold>
###xml 114 124 114 124 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. murina </italic>
###xml 143 144 143 144 <bold xmlns:xlink="http://www.w3.org/1999/xlink">A</bold>
###xml 154 155 154 155 <bold xmlns:xlink="http://www.w3.org/1999/xlink">B</bold>
###xml 168 169 168 169 <bold xmlns:xlink="http://www.w3.org/1999/xlink">C</bold>
###xml 255 265 255 265 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. murina </italic>
###xml 407 411 405 409 <sub xmlns:xlink="http://www.w3.org/1999/xlink">405 </sub>
###xml 16 25 <span type="species:ncbi:263815">P. murina</span>
###xml 104 106 <span type="species:ncbi:10090">KO</span>
###xml 108 112 <span type="species:ncbi:10090">mice</span>
###xml 114 123 <span type="species:ncbi:263815">P. murina</span>
###xml 214 216 <span type="species:ncbi:10090">KO</span>
###xml 217 221 <span type="species:ncbi:10090">mice</span>
###xml 255 264 <span type="species:ncbi:263815">P. murina</span>
###xml 291 295 <span type="species:ncbi:10090">mice</span>
###xml 349 353 <span type="species:ncbi:10090">mice</span>
###xml 436 438 <span type="species:ncbi:10090">KO</span>
Analysis of the P. murina serum antibody response in immunocompetent Wild-Type (WT) and SP-A deficient (KO) mice. P. murina MSG specific IgG1 (A), IgG2a (B) and IgG2b (C) serum antibodies in immunocompetent WT and KO mice with no experimental exposure to P. murina were analyzed by ELISA in mice 4, 6, 8, and 10 weeks of age. Each group contained 4 mice. Data are expressed as the Mean +/- the SEM of the OD405 for each group *p < 0.01 KO vs. WT at time point, +p < 0.01 increase over time within a group, as determined by ANOVA.
###end p 57
###begin title 58
###xml 16 18 <span type="species:ncbi:10090">KO</span>
###xml 19 23 <span type="species:ncbi:10090">mice</span>
Immunocompetent KO mice display an enhanced cellular pulmonary immune response
###end title 58
###begin p 59
###xml 50 60 50 60 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. murina </italic>
###xml 274 284 274 284 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. murina </italic>
###xml 468 469 468 469 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5</xref>
###xml 646 648 646 648 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5A</xref>
###xml 885 887 885 887 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5B</xref>
###xml 50 59 <span type="species:ncbi:263815">P. murina</span>
###xml 80 82 <span type="species:ncbi:10090">KO</span>
###xml 83 87 <span type="species:ncbi:10090">mice</span>
###xml 135 139 <span type="species:ncbi:10090">Mice</span>
###xml 274 283 <span type="species:ncbi:263815">P. murina</span>
###xml 348 350 <span type="species:ncbi:10090">KO</span>
###xml 387 391 <span type="species:ncbi:10090">mice</span>
###xml 545 547 <span type="species:ncbi:10090">KO</span>
###xml 548 552 <span type="species:ncbi:10090">mice</span>
###xml 566 570 <span type="species:ncbi:10090">mice</span>
###xml 633 635 <span type="species:ncbi:10090">KO</span>
###xml 636 640 <span type="species:ncbi:10090">mice</span>
###xml 668 670 <span type="species:ncbi:10090">KO</span>
###xml 671 675 <span type="species:ncbi:10090">mice</span>
###xml 712 716 <span type="species:ncbi:10090">mice</span>
###xml 865 867 <span type="species:ncbi:10090">KO</span>
###xml 875 879 <span type="species:ncbi:10090">mice</span>
###xml 1025 1027 <span type="species:ncbi:10090">KO</span>
###xml 1028 1032 <span type="species:ncbi:10090">mice</span>
###xml 1048 1052 <span type="species:ncbi:10090">mice</span>
These analyses were performed to determine if the P. murina colonization in the KO mice stimulates a cellular pulmonary host response. Mice 6-8 weeks of age were chosen for these analyses because it was predicted that the pulmonary cellular response may precede the peak of P. murina colonization. Mononuclear cells were isolated from the lungs of KO and WT 6-8 week old immunocompetent mice and CD4+ and CD8+ T cell populations were enumerated by flow cytometry (Fig 5). Significantly more CD4+ and CD8+ T cells were isolated from the lungs of KO mice than from WT mice and the CD4+:CD8+ T-cell ratio was significantly lower in the KO mice (Fig 5A). The ratio in the KO mice was approximately 1.5 and in the WT mice it was 2.2. The reason behind the alteration of the CD4+:CD8+ T-cell ratio is reflected by the comparison of the percentages of these cell types in KO and WT mice (Fig 5B). A significantly lower percentage of CD4+ T-cells and a corresponding significantly higher percentage of CD8+ T-cells were found in the KO mice than in the WT mice.
###end p 59
###begin p 60
###xml 0 113 0 113 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Analysis of the cellular pulmonary immune response in immunocompetent SP-A deficient (KO) and Wild-Type (WT) mice</bold>
###xml 213 222 213 222 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. murina</italic>
###xml 342 343 342 343 <bold xmlns:xlink="http://www.w3.org/1999/xlink">A</bold>
###xml 393 394 391 392 <bold xmlns:xlink="http://www.w3.org/1999/xlink">B</bold>
###xml 86 88 <span type="species:ncbi:10090">KO</span>
###xml 109 113 <span type="species:ncbi:10090">mice</span>
###xml 165 167 <span type="species:ncbi:10090">KO</span>
###xml 175 179 <span type="species:ncbi:10090">mice</span>
###xml 213 222 <span type="species:ncbi:263815">P. murina</span>
###xml 386 391 <span type="species:ncbi:10090">mouse</span>
###xml 441 446 <span type="species:ncbi:10090">mouse</span>
###xml 462 466 <span type="species:ncbi:10090">mice</span>
###xml 474 476 <span type="species:ncbi:10090">KO</span>
###xml 489 493 <span type="species:ncbi:10090">mice</span>
###xml 522 524 <span type="species:ncbi:10090">KO</span>
Analysis of the cellular pulmonary immune response in immunocompetent SP-A deficient (KO) and Wild-Type (WT) mice. Mononuclear cells were isolated from the lungs of KO and WT mice with no experimental exposure to P. murina. CD4+ and CD8+ T cell populations were identified by cell surface antibody labeling and quantitated by flow cytometry. A. Mean +/- the SEM of the number cells per mouse. B. Mean percentage of CD4+ and CD8+ T cells per mouse. There were 10 mice in the KO group and 8 mice in the WT group. * p < 0.01 KO vs. WT as determined by t test.
###end p 60
###begin title 61
###xml 44 54 44 54 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. murina </italic>
###xml 44 53 <span type="species:ncbi:263815">P. murina</span>
###xml 72 74 <span type="species:ncbi:10090">KO</span>
###xml 75 79 <span type="species:ncbi:10090">mice</span>
CD4+ T cell depletion inhibits clearance of P. murina from the lungs of KO mice
###end title 61
###begin p 62
###xml 221 231 221 231 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. murina </italic>
###xml 442 452 442 452 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. murina </italic>
###xml 613 623 613 623 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. murina </italic>
###xml 642 643 642 643 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T2">2</xref>
###xml 768 770 768 770 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6A</xref>
###xml 822 832 822 832 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. murina </italic>
###xml 875 877 875 877 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6B</xref>
###xml 880 890 880 890 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. murina </italic>
###xml 1021 1022 1021 1022 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T2">2</xref>
###xml 38 40 <span type="species:ncbi:10090">KO</span>
###xml 41 45 <span type="species:ncbi:10090">mice</span>
###xml 187 189 <span type="species:ncbi:10090">KO</span>
###xml 190 194 <span type="species:ncbi:10090">mice</span>
###xml 199 201 <span type="species:ncbi:10090">KO</span>
###xml 202 206 <span type="species:ncbi:10090">mice</span>
###xml 221 230 <span type="species:ncbi:263815">P. murina</span>
###xml 340 344 <span type="species:ncbi:10090">mice</span>
###xml 442 451 <span type="species:ncbi:263815">P. murina</span>
###xml 507 509 <span type="species:ncbi:10090">KO</span>
###xml 510 514 <span type="species:ncbi:10090">mice</span>
###xml 536 538 <span type="species:ncbi:10090">KO</span>
###xml 539 543 <span type="species:ncbi:10090">mice</span>
###xml 613 622 <span type="species:ncbi:263815">P. murina</span>
###xml 718 722 <span type="species:ncbi:10090">mice</span>
###xml 822 831 <span type="species:ncbi:263815">P. murina</span>
###xml 880 889 <span type="species:ncbi:263815">P. murina</span>
###xml 941 945 <span type="species:ncbi:10090">mice</span>
###xml 971 975 <span type="species:ncbi:10090">mice</span>
###xml 1105 1109 <span type="species:ncbi:10090">mice</span>
###xml 1136 1140 <span type="species:ncbi:10090">mice</span>
###xml 1190 1192 <span type="species:ncbi:10090">KO</span>
###xml 1193 1197 <span type="species:ncbi:10090">mice</span>
###xml 1264 1266 <span type="species:ncbi:10090">KO</span>
###xml 1267 1271 <span type="species:ncbi:10090">mice</span>
The previous results demonstrate that KO mice harbor higher levels of CD4+ T-cells in their lungs. To determine if CD4+ T-cell depletion inhibits clearance of the colonization, unexposed KO mice and KO mice infected with P. murina by intratracheal inoculation, were depleted of CD4+ T-cells by treatment with Gk1.5 antibody. After 4 weeks, mice were sacrificed and the level of infection was evaluated by microscopic enumeration and by qPCR. P. murina cyst forms were detected in only 4 out of 10 unexposed KO mice whereas 15 out of 15 KO mice infected by intratracheal inoculation developed detectable levels of P. murina cysts forms (Table 2). In addition, there were significantly fewer cyst forms in the unexposed mice that had detectable levels of organisms (Fig 6A). The lungs were also analyzed for the presence of P. murina by qPCR detection of mtLSU expression (Fig 6B). P. murina was detected by this assay in all of the unexposed mice as well as in all of the mice infected by intratracheal inoculation (Table 2). Significantly higher levels of mtLSU expression were detected in the inoculated mice compared to the unexposed mice. The level of infection present in the unexposed KO mice was higher than levels previously detected in the immunocompetent KO mice.
###end p 62
###begin p 63
###xml 86 96 86 96 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. murina </italic>
###xml 55 59 <span type="species:ncbi:10090">mice</span>
###xml 86 95 <span type="species:ncbi:263815">P. murina</span>
Percentages of unexposed and inoculated SP-A deficient mice with detectable levels of P. murina following CD4 cell depletion.
###end p 63
###begin p 64
###xml 44 54 44 54 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. murina </italic>
###xml 0 96 0 96 <bold xmlns:xlink="http://www.w3.org/1999/xlink">CD4+ T cell depletion inhibits clearance of <italic>P. murina </italic>from the lungs of SP-A deficient (KO) mice</bold>
###xml 120 130 120 130 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. murina </italic>
###xml 271 281 271 281 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. murina </italic>
###xml 372 382 372 382 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. murina </italic>
###xml 469 472 469 472 <sub xmlns:xlink="http://www.w3.org/1999/xlink">10 </sub>
###xml 542 545 542 545 <sub xmlns:xlink="http://www.w3.org/1999/xlink">10 </sub>
###xml 626 636 624 634 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. murina </italic>
###xml 44 53 <span type="species:ncbi:263815">P. murina</span>
###xml 88 90 <span type="species:ncbi:10090">KO</span>
###xml 92 96 <span type="species:ncbi:10090">mice</span>
###xml 98 100 <span type="species:ncbi:10090">KO</span>
###xml 101 105 <span type="species:ncbi:10090">mice</span>
###xml 120 129 <span type="species:ncbi:263815">P. murina</span>
###xml 172 174 <span type="species:ncbi:10090">KO</span>
###xml 175 179 <span type="species:ncbi:10090">mice</span>
###xml 271 280 <span type="species:ncbi:263815">P. murina</span>
###xml 372 381 <span type="species:ncbi:263815">P. murina</span>
###xml 626 635 <span type="species:ncbi:263815">P. murina</span>
CD4+ T cell depletion inhibits clearance of P. murina from the lungs of SP-A deficient (KO) mice. KO mice infected with P. murina by intratracheal inoculation or unexposed KO mice were treated with a CD4 depleting antibody for four weeks. The animals were sacrificed and P. murina infection was evaluated by microscopic enumeration of cyst forms or by quantitation of the P. murina large mitochondrial ribosomal RNA gene by qPCR. The cyst form data are expressed as log10 cyst forms per lung. The level of sensitivity in this assay is 4.4 log10 cyst forms per lung. The qPCR data are the mean +/- the SEM and are expressed as P. murina nuclei per reaction. *p < 0.05 as determined by t test.
###end p 64
###begin title 65
Discussion
###end title 65
###begin p 66
###xml 129 139 129 139 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. murina </italic>
###xml 187 203 187 203 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pneumocystis spp</italic>
###xml 476 478 476 478 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B36">36</xref>
###xml 479 481 479 481 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B39">39</xref>
###xml 515 528 515 528 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. jirovecii </italic>
###xml 636 638 636 638 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B40">40</xref>
###xml 639 641 639 641 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B42">42</xref>
###xml 719 732 719 732 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. jirovecii </italic>
###xml 805 807 805 807 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B43">43</xref>
###xml 808 810 808 810 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B44">44</xref>
###xml 910 923 910 923 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. jirovecii </italic>
###xml 1139 1141 1139 1141 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B45">45</xref>
###xml 1142 1144 1142 1144 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B46">46</xref>
###xml 64 66 <span type="species:ncbi:10090">KO</span>
###xml 67 71 <span type="species:ncbi:10090">mice</span>
###xml 84 88 <span type="species:ncbi:10090">mice</span>
###xml 129 138 <span type="species:ncbi:263815">P. murina</span>
###xml 218 224 <span type="species:ncbi:9606">humans</span>
###xml 427 448 <span type="species:ncbi:328819|species:ncbi:379362|species:ncbi:219650|species:ncbi:329529|species:ncbi:133823|species:ncbi:261389|species:ncbi:184426|species:ncbi:261384|species:ncbi:302169">environmental samples</span>
###xml 484 489 <span type="species:ncbi:9606">Human</span>
###xml 493 498 <span type="species:ncbi:9606">human</span>
###xml 515 527 <span type="species:ncbi:42068">P. jirovecii</span>
###xml 686 692 <span type="species:ncbi:9606">person</span>
###xml 696 702 <span type="species:ncbi:9606">person</span>
###xml 719 731 <span type="species:ncbi:42068">P. jirovecii</span>
###xml 910 922 <span type="species:ncbi:42068">P. jirovecii</span>
###xml 1108 1114 <span type="species:ncbi:9606">person</span>
###xml 1118 1124 <span type="species:ncbi:9606">person</span>
The results of these studies indicate that immunocompetent SP-A KO mice, but not WT mice, harbor viable and actively replicating P. murina following environmental exposure. The source of Pneumocystis spp. infection in humans and animals remains unknown. Various species have been detected by environmental sampling techniques, suggesting a possible environmental source of the infection; yet, the infectious potential of these environmental samples has not been demonstrated [36-39]. Human-to-human transmission of P. jirovecii has been identified by epidemiology studies that identified direct transmission and clusters of infections [40-42]. Conversely, other studies determined that person-to-person transmission of P. jirovecii did not appear to contribute significantly to the spread of the disease [43,44]. Several studies have demonstrated that recurrence of PcP following successful treatment involves P. jirovecii of a different strain from the initial infection, suggesting that the recurrence is the result of infection from an exogenous source that may be either due to environmental exposure or person-to-person transmission [45,46].
###end p 66
###begin p 67
###xml 93 106 93 106 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. jirovecii </italic>
###xml 168 170 168 170 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B47">47</xref>
###xml 386 399 386 399 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. jirovecii </italic>
###xml 461 463 461 463 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B48">48</xref>
###xml 464 466 464 466 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B50">50</xref>
###xml 565 578 565 578 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. jirovecii </italic>
###xml 579 581 579 581 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B51">51</xref>
###xml 611 624 611 624 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. jirovecii </italic>
###xml 93 105 <span type="species:ncbi:42068">P. jirovecii</span>
###xml 160 166 <span type="species:ncbi:9606">humans</span>
###xml 386 398 <span type="species:ncbi:42068">P. jirovecii</span>
###xml 565 577 <span type="species:ncbi:42068">P. jirovecii</span>
###xml 611 623 <span type="species:ncbi:42068">P. jirovecii</span>
The development of sensitive PCR techniques led to the search for the presence of low levels P. jirovecii in the lungs of immunocompetent and immunocompromised humans [47]. It had long been thought Pneumocystis remained in a latent stage within the lungs of immunocompetent individuals and became reactivated during immunosuppression; however, results from early studies indicated that P. jirovecii was not present in lungs of non-immunosuppressed individuals [48-50]. In addition, a more recent study also indicated that healthy subjects may not be colonized with P. jirovecii [51]. These results suggest that P. jirovecii does not exist in a latent stage in immunocompetent individuals.
###end p 67
###begin p 68
###xml 10 23 10 23 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. jirovecii </italic>
###xml 77 90 77 90 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. jirovecii </italic>
###xml 285 287 285 287 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B52">52</xref>
###xml 331 344 331 344 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. jirovecii </italic>
###xml 534 547 534 547 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. jirovecii </italic>
###xml 548 550 548 550 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B53">53</xref>
###xml 578 591 578 591 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. jirovecii </italic>
###xml 670 671 670 671 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 993 994 993 994 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B8">8</xref>
###xml 997 1009 997 1009 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P jirovecii </italic>
###xml 1201 1203 1201 1203 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B54">54</xref>
###xml 10 22 <span type="species:ncbi:42068">P. jirovecii</span>
###xml 77 89 <span type="species:ncbi:42068">P. jirovecii</span>
###xml 143 151 <span type="species:ncbi:9606">patients</span>
###xml 225 232 <span type="species:ncbi:9606">patient</span>
###xml 331 343 <span type="species:ncbi:42068">P. jirovecii</span>
###xml 360 363 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 379 387 <span type="species:ncbi:9606">patients</span>
###xml 476 479 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 482 490 <span type="species:ncbi:9606">patients</span>
###xml 534 546 <span type="species:ncbi:42068">P. jirovecii</span>
###xml 578 590 <span type="species:ncbi:42068">P. jirovecii</span>
###xml 652 655 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 883 890 <span type="species:ncbi:9606">persons</span>
###xml 905 908 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 1025 1033 <span type="species:ncbi:9606">patients</span>
Although, P. jirovecii colonization was not detected in healthy individuals, P. jirovecii colonization has been described in some hospitalized patients with moderate to severe underlying immunodeficiency suggesting that this patient population could serve as a reservoir of infection [52]. Results from a recent study suggest that P. jirovecii colonization in HIV + hospitalized patients may also be a source of infection. In that study, it was found that 68% of hospitalized HIV + patients with non PcP pneumonia were colonized with P. jirovecii [53]. In another recent study, P. jirovecii colonization was detected in 46% of the autopsy specimens of HIV+ individuals [7]. Also, in that study, cigarette smoking and city of residence were discovered to be risk factors for colonization. In a study, examining bronchoalveolar specimens, a lower level of colonization was detected in persons infected with HIV, but these authors also propose that this carriage may be a reservoir of infection [8]. P jirovecii colonization in patients with other lung diseases such as cystic fibrosis and chronic obstruction pulmonary disease, without significant underlying immunosuppression, has also been described [54].
###end p 68
###begin p 69
###xml 46 59 46 59 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. jirovecii </italic>
###xml 114 116 114 116 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B55">55</xref>
###xml 243 245 243 245 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B56">56</xref>
###xml 246 248 246 248 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B57">57</xref>
###xml 293 306 293 306 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. jirovecii </italic>
###xml 425 427 425 427 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B58">58</xref>
###xml 46 58 <span type="species:ncbi:42068">P. jirovecii</span>
###xml 293 305 <span type="species:ncbi:42068">P. jirovecii</span>
###xml 338 346 <span type="species:ncbi:9606">patients</span>
The findings of an early study indicated that P. jirovecii colonization was not associated with cystic fibrosis. [55]. However, in two more recent studies colonization rates of 7.4% and 21.5% were detected in individuals with cystic fibrosis [56,57]. Interestingly, it has also been show that P. jirovecii colonization in cystic fibrosis patients is a dynamic process, in which clearance and recolonization occurs over time [58].
###end p 69
###begin p 70
###xml 19 32 19 32 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. jirovecii </italic>
###xml 420 422 420 422 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B59">59</xref>
###xml 425 438 425 438 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. jirovecii </italic>
###xml 705 707 705 707 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B11">11</xref>
###xml 710 723 710 723 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. jirovecii </italic>
###xml 900 902 900 902 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 1422 1423 1422 1423 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 19 31 <span type="species:ncbi:42068">P. jirovecii</span>
###xml 48 56 <span type="species:ncbi:9606">patients</span>
###xml 319 327 <span type="species:ncbi:9606">patients</span>
###xml 425 437 <span type="species:ncbi:42068">P. jirovecii</span>
###xml 710 722 <span type="species:ncbi:42068">P. jirovecii</span>
###xml 739 746 <span type="species:ncbi:9606">persons</span>
###xml 989 997 <span type="species:ncbi:9606">patients</span>
###xml 1404 1407 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
Several reports of P. jirovecii colonization in patients with chronic obstructive pulmonary disease (COPD) have been published. In an early study, a colonization rate of only 10% was detected and the authors postulated that since this rate of colonization was similar to the rate of PcP being seen in immunocompromised patients at their site, PcP arose from a latent infection and was not the result of a new infection [59]. P. jirovecii colonization has also been linked with severity of COPD as measured by spirometric lung function in a study that examined autopsy specimens. In that study, colonization was detected in 37% of smokers with severe COPD, but only 5.3% of those with less severe disease [11]. P. jirovecii colonization in persons with COPD has also been associated with higher levels proinflammatory cytokines, suggesting that the host mounts an immune response to the colonization [12]. In this study, colonization was detected in 55% of induced sputum samples from COPD patients, a much higher rate of colonization than previously reported. The variation in reported colonization rates may be related to the type of samples that were tested or due to differences in the detection methods that were used. Alternatively, the different colonization rates may indicate that some demographic areas may have higher rates of colonization than others, as was reported in colonization rates in HIV+ individuals [7].
###end p 70
###begin p 71
###xml 130 146 130 146 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pneumocystis spp</italic>
###xml 206 216 206 216 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. murina </italic>
###xml 338 340 338 340 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B60">60</xref>
###xml 341 343 341 343 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B61">61</xref>
###xml 526 527 526 527 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B5">5</xref>
###xml 528 530 528 530 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B62">62</xref>
###xml 712 714 712 714 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B60">60</xref>
###xml 715 717 715 717 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B62">62</xref>
###xml 176 181 <span type="species:ncbi:10090">mouse</span>
###xml 206 215 <span type="species:ncbi:263815">P. murina</span>
###xml 258 262 <span type="species:ncbi:10090">mice</span>
###xml 356 360 <span type="species:ncbi:10090">mice</span>
###xml 540 544 <span type="species:ncbi:10090">mice</span>
Animal-to-animal spread of the infection has been well documented and supports the role of immunocompetent hosts as reservoirs of Pneumocystis spp. infection. In studies using mouse models, transmission of P. murina infection through cohousing with infected mice initiates infection in both immunocompetent and immunocompromised animals [60,61]. In normal mice, the colonization is self-limiting; immune-mediated clearance occurs 5-6 weeks post initiation of infection and involves both humoral and cellular immune responses [5,62]. Normal mice with this transient colonization have also been shown to be able to transmit the infection, further supporting the normal host as a reservoir of infectious organisms [60,62].
###end p 71
###begin p 72
###xml 54 64 54 64 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. murina </italic>
###xml 170 180 170 180 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. murina </italic>
###xml 184 195 184 195 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. carinii </italic>
###xml 287 300 287 300 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pneumocystis </italic>
###xml 570 572 570 572 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B63">63</xref>
###xml 687 697 687 697 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. murina </italic>
###xml 1114 1116 1114 1116 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B64">64</xref>
###xml 1221 1231 1221 1231 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. murina </italic>
###xml 1315 1317 1315 1317 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B65">65</xref>
###xml 1318 1320 1318 1320 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B66">66</xref>
###xml 1534 1547 1534 1547 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pneumocystis </italic>
###xml 1561 1563 1561 1563 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B66">66</xref>
###xml 1564 1566 1564 1566 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B67">67</xref>
###xml 54 63 <span type="species:ncbi:263815">P. murina</span>
###xml 170 179 <span type="species:ncbi:263815">P. murina</span>
###xml 184 194 <span type="species:ncbi:4754">P. carinii</span>
###xml 687 696 <span type="species:ncbi:263815">P. murina</span>
###xml 748 752 <span type="species:ncbi:10090">mice</span>
###xml 902 904 <span type="species:ncbi:10090">KO</span>
###xml 905 909 <span type="species:ncbi:10090">mice</span>
###xml 1037 1040 <span type="species:ncbi:10116">rat</span>
###xml 1149 1154 <span type="species:ncbi:10090">mouse</span>
###xml 1221 1230 <span type="species:ncbi:263815">P. murina</span>
###xml 1280 1285 <span type="species:ncbi:10090">mouse</span>
It was surprising to detect environmental exposure of P. murina within our barrier animal facility; however, this finding may not be totally unexpected. Previously, both P. murina and P. carinii outbreaks have been described in commercial animal facilities, demonstrating the ability of Pneumocystis to circumvent isolation systems designed to limit cage-to-cage exposure. It has been shown that air may circulate into cages with micro isolator tops not through the filter on top of the cage, but rather through the edges of the cage which may not be rigorously sealed [63]. Even though cages are changed within a laminar flow hood, another source of potential environmental exposure to P. murina would be during cage changing procedures. Cages of mice used in these studies were changed 2-3 times per week which may have lead to increased environmental exposure and development of colonization in the KO mice. This could result in cross-contamination of cages within the colony. Colonization is a very common finding in immunocompetent rat colonies that have been screened by PCR, but it usually goes undetected [64]. A systematic survey of normal mouse colonies has not been performed, but both colonization and active P. murina infection in several genetically immunodeficient mouse colonies has been described [65,66]. These findings demonstrate that colonization of laboratory animals occurs in spite of maintenance of strict barrier conditions, and suggests that these practices are not sufficient to prevent the development of Pneumocystis colonization [66,67].
###end p 72
###begin p 73
###xml 66 76 66 76 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. murina </italic>
###xml 163 173 163 173 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. murina </italic>
###xml 254 264 254 264 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. murina </italic>
###xml 349 359 349 359 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. murina </italic>
###xml 499 512 499 512 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pneumocystis </italic>
###xml 544 581 544 581 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Development of transient colonization</italic>
###xml 601 614 601 614 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pneumocystis </italic>
###xml 760 823 760 823 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Elimination of Pneumocystis without development of colonization</italic>
###xml 901 914 901 914 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pneumocystis </italic>
###xml 35 37 <span type="species:ncbi:10090">KO</span>
###xml 38 42 <span type="species:ncbi:10090">mice</span>
###xml 66 75 <span type="species:ncbi:263815">P. murina</span>
###xml 163 172 <span type="species:ncbi:263815">P. murina</span>
###xml 218 222 <span type="species:ncbi:10090">mice</span>
###xml 230 234 <span type="species:ncbi:10090">mice</span>
###xml 254 263 <span type="species:ncbi:263815">P. murina</span>
###xml 337 339 <span type="species:ncbi:10090">KO</span>
###xml 340 344 <span type="species:ncbi:10090">mice</span>
###xml 349 358 <span type="species:ncbi:263815">P. murina</span>
In the present report, both WT and KO mice apparently encountered P. murina through environmental exposure within the animal facility, based on the development of P. murina specific serum antibodies in both strains of mice. In WT mice, it seems that the P. murina is eliminated from the lungs and never establishes an infection; yet, in KO mice the P. murina establishes a transient colonization. Based on these results, we propose that there are two potential outcomes of environmental exposure to Pneumocystis in the immunocompetent host: 1) Development of transient colonization. In this scenario, Pneumocystis escapes detection by the innate immune response and establishes a colonization that may be eventually cleared by the adaptive immune response. 2) Elimination of Pneumocystis without development of colonization. In this situation, the innate immune response recognizes and eliminates the Pneumocystis prior to it being able to establish an active infection.
###end p 73
###begin p 74
###xml 228 238 228 238 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. murina </italic>
###xml 487 492 487 492 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SCID </italic>
###xml 609 614 609 614 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SCID </italic>
###xml 908 913 908 913 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SCID </italic>
###xml 999 1004 999 1004 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SCID </italic>
###xml 1183 1192 1183 1192 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. murina</italic>
###xml 1268 1281 1268 1281 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pneumocystis </italic>
###xml 1327 1337 1327 1337 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. murina </italic>
###xml 1463 1473 1463 1473 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. murina </italic>
###xml 1744 1754 1744 1754 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. murina </italic>
###xml 110 114 <span type="species:ncbi:10090">mice</span>
###xml 214 216 <span type="species:ncbi:10090">KO</span>
###xml 228 237 <span type="species:ncbi:263815">P. murina</span>
###xml 492 496 <span type="species:ncbi:10090">mice</span>
###xml 614 618 <span type="species:ncbi:10090">mice</span>
###xml 697 702 <span type="species:ncbi:10090">mouse</span>
###xml 913 917 <span type="species:ncbi:10090">mice</span>
###xml 1004 1008 <span type="species:ncbi:10090">mice</span>
###xml 1127 1131 <span type="species:ncbi:10090">mice</span>
###xml 1183 1192 <span type="species:ncbi:263815">P. murina</span>
###xml 1327 1336 <span type="species:ncbi:263815">P. murina</span>
###xml 1422 1428 <span type="species:ncbi:9606">humans</span>
###xml 1463 1472 <span type="species:ncbi:263815">P. murina</span>
###xml 1571 1575 <span type="species:ncbi:10090">mice</span>
###xml 1744 1753 <span type="species:ncbi:263815">P. murina</span>
It is likely that the level of environmental exposure within the animal facility is very low and sporadic. WT mice appear to be able to defend against such a low level exposure; however, the absence of SP-A in the KO allows the P. murina to escape innate host responses, which are likely to be involved in protection of the host from initial infection. It is interesting to note that at the time that these studies were performed at the UC LAM facility, colonization was not detected in SCID mice housed under the same conditions in microisolator cages. It was thought that the absence of colonization in the SCID mice reflected the presence of SP-A and/or residual immune function. Recently, our mouse colonies have been relocated to a different animal facility. The housing conditions in this facility are similar to conditions used in the previous facility, but sporadic colonization has been observed in SCID mice housed in microisolator cages in this facility. These new findings indicate that SCID mice are susceptible to development of colonization following environmental exposure, and support the idea that all of the mice within the facility are environmentally exposed to P. murina. These data also emphasize the complexities of developing animal models of Pneumocystis colonization. On the one hand, acquisition of P. murina colonization via natural environmental exposure most closely mimics the situation in humans, as other methods of transmitting P. murina such as intratracheal inoculation, intranasal inoculation, or co-housing infected with uninfected mice ("seeding") involve larger or more intense types of exposure. On the other hand, environmental exposure studies are uncontrolled and become difficult to interpret when P. murina infection already exists in some members of an animal colony.
###end p 74
###begin p 75
###xml 57 67 57 67 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. murina </italic>
###xml 585 598 585 598 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pneumocystis </italic>
###xml 30 32 <span type="species:ncbi:10090">KO</span>
###xml 33 37 <span type="species:ncbi:10090">mice</span>
###xml 57 66 <span type="species:ncbi:263815">P. murina</span>
###xml 268 270 <span type="species:ncbi:10090">KO</span>
###xml 271 275 <span type="species:ncbi:10090">mice</span>
###xml 295 299 <span type="species:ncbi:10090">mice</span>
###xml 392 394 <span type="species:ncbi:10090">KO</span>
###xml 395 399 <span type="species:ncbi:10090">mice</span>
Although immunocompetent SP-A KO mice are susceptible to P. murina colonization, they can limit and ultimately clear the infection. Not surprisingly, CD4+ T cells appear to play an important role in this process. Increased numbers of CD4+ T-cells were detected in the KO mice compared to the WT mice, and antibody mediated CD4+ T-cells depletion resulted in higher levels of infection in the KO mice. Further characterization of the SP-A independent factors involved in clearance of colonization will provide insight into the mechanisms immunocompetent hosts utilize to defend against Pneumocystis infection.
###end p 75
###begin p 76
###xml 198 200 198 200 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 435 445 435 445 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. murina </italic>
###xml 466 468 466 468 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 640 642 640 642 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 800 802 800 802 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 974 976 974 976 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B68">68</xref>
###xml 347 349 <span type="species:ncbi:10090">KO</span>
###xml 350 354 <span type="species:ncbi:10090">mice</span>
###xml 435 444 <span type="species:ncbi:263815">P. murina</span>
###xml 645 647 <span type="species:ncbi:10090">KO</span>
###xml 648 652 <span type="species:ncbi:10090">mice</span>
###xml 848 852 <span type="species:ncbi:10090">mice</span>
###xml 968 972 <span type="species:ncbi:10090">mice</span>
###xml 1082 1084 <span type="species:ncbi:10090">KO</span>
###xml 1085 1089 <span type="species:ncbi:10090">mice</span>
SP-A is a member of the collectin family of proteins, innate immune molecules containing a collagen-like amino terminus and a C-type lectin carbohydrate recognition domain at the carboxyl terminus [15]. Structurally similar to C1q, mannose-binding protein and surfactant protein D (SP-D), it is secreted by type II alveolar epithelial cells. SP-A KO mice have provided valuable information on the role of SP-A in host defenses against P. murina and other organisms [17]. These animals have normal lung morphology, physiology, surfactant phospholipids and other surfactant proteins (SP-B, SP-C or SP-D), but are deficient in tubular myelin [16]. KO mice have impaired clearance of infectious agents following experimental exposure, which is usually accompanied by increased proinflammatory cytokines [17]. A recent study demonstrated that SP-A null mice raised in an environment heavily contaminated with bacteria were more susceptible to bacterial peritonitis than WT mice [68]. Although the lungs were not involved in the infection in this model, the results demonstrate that SP-A KO mice may also be susceptible to infections following environmental exposure.
###end p 76
###begin p 77
###xml 88 98 88 98 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. murina </italic>
###xml 184 186 184 186 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B24">24</xref>
###xml 187 189 187 189 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B25">25</xref>
###xml 317 319 317 319 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B69">69</xref>
###xml 365 375 365 375 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. murina </italic>
###xml 568 570 568 570 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B34">34</xref>
###xml 56 58 <span type="species:ncbi:10090">KO</span>
###xml 59 63 <span type="species:ncbi:10090">mice</span>
###xml 88 97 <span type="species:ncbi:263815">P. murina</span>
###xml 178 182 <span type="species:ncbi:10090">mice</span>
###xml 208 210 <span type="species:ncbi:10090">KO</span>
###xml 211 215 <span type="species:ncbi:10090">mice</span>
###xml 311 315 <span type="species:ncbi:10090">mice</span>
###xml 365 374 <span type="species:ncbi:263815">P. murina</span>
###xml 396 401 <span type="species:ncbi:10090">mouse</span>
###xml 437 439 <span type="species:ncbi:10090">KO</span>
###xml 440 444 <span type="species:ncbi:10090">mice</span>
###xml 493 497 <span type="species:ncbi:10090">mice</span>
It has been previously shown that immunosuppressed SP-A KO mice are more susceptible to P. murina infection, and when immunosuppressed, they develop higher levels of PcP than WT mice [24,25]. Immunocompetent KO mice also display delayed clearance following infection by intratracheal inoculation compared to WT mice [69]. However, SP-A did not enhance clearance of P. murina in a steroid treated mouse model of infection. In this model, KO mice cleared the infection just as efficiently as WT mice following withdrawal of the corticosteroid induced immunosuppression [34].
###end p 77
###begin p 78
###xml 232 234 232 234 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B70">70</xref>
###xml 330 343 330 343 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pneumocystis </italic>
###xml 374 387 374 387 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pneumocystis </italic>
###xml 451 453 451 453 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B71">71</xref>
###xml 454 456 454 456 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B72">72</xref>
###xml 495 504 495 504 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. murina</italic>
###xml 612 614 612 614 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B24">24</xref>
###xml 495 504 <span type="species:ncbi:263815">P. murina</span>
###xml 530 532 <span type="species:ncbi:10090">KO</span>
###xml 533 537 <span type="species:ncbi:10090">mice</span>
###xml 584 589 <span type="species:ncbi:10090">mouse</span>
SP-A plays a role in early host defenses by enhancing the uptake of infectious agents by alveolar macrophages and has been shown to facilitate the adherence and/or phagocytosis of most of the organisms with which it has been tested[70]. In vitro studies have demonstrated that under certain conditions SP-A enhances attachment of Pneumocystis to AMs; however, inhibition of Pneumocystis binding to alveolar macrophages by SP-A has also been reported [71,72]. In our laboratory, preincubation of P. murina, which was isolated from KO mice, with SP-A resulted in enhanced attachment to mouse alveolar macrophages [24].
###end p 78
###begin p 79
###xml 112 133 112 133 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mycoplasma pneumoniae</italic>
###xml 139 162 139 162 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Histoplasma capsulatum </italic>
###xml 216 218 216 218 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B23">23</xref>
###xml 350 352 350 352 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 495 497 495 497 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 606 608 606 608 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B73">73</xref>
###xml 757 759 757 759 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B74">74</xref>
###xml 888 890 888 890 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B75">75</xref>
###xml 973 985 973 985 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pneumocystis</italic>
###xml 112 133 <span type="species:ncbi:2104">Mycoplasma pneumoniae</span>
###xml 139 161 <span type="species:ncbi:5037">Histoplasma capsulatum</span>
SP-A also displays other protective activities in the host response. Binding of SP-A to gram-negative bacteria, Mycoplasma pneumoniae, and Histoplasma capsulatum has been shown to result in killing of the organisms [23]. SP-A also increases aggregation of organisms that leads to enhanced clearance from the respiratory tract by mucociliary actions [17]. In addition to these direct activities, SP-A interacts with a variety of immune cells and modulates their responses to pulmonary pathogens [15]. SP-A has been shown to inhibit maturation of dendritic cells and limit their ability to activate T cells [73]. In addition to its regulation of the innate immune response, there is rising interest in the interaction of SP-A with the adaptive immune system [74]. A recent report showed that SP-A binds to the Fc portion of IgG and facilitates the uptake of IgG coated erythrocytes by AMs [75]. These other SP-A activities have not been characterized in the host response to Pneumocystis; however, it is likely that prevention of colonization involves both innate and adaptive immune response mechanisms and that SP-A may have additional activities beyond enhancing uptake by alveolar macrophages.
###end p 79
###begin p 80
###xml 95 105 95 105 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. murina </italic>
###xml 173 183 173 183 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. murina </italic>
###xml 312 322 312 322 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. murina </italic>
###xml 426 436 426 436 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. murina </italic>
###xml 461 463 461 463 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B23">23</xref>
###xml 464 466 464 466 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B23">23</xref>
###xml 467 469 467 469 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B72">72</xref>
###xml 470 472 470 472 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B76">76</xref>
###xml 95 104 <span type="species:ncbi:263815">P. murina</span>
###xml 173 182 <span type="species:ncbi:263815">P. murina</span>
###xml 312 321 <span type="species:ncbi:263815">P. murina</span>
###xml 426 435 <span type="species:ncbi:263815">P. murina</span>
The current study demonstrates a new role for SP-A in protecting the immunocompetent host from P. murina infection by preventing the normal host from becoming infected with P. murina following environmental exposure. The protective effects of SP-A in this situation, may involve direct action of the molecule on P. murina viability, indirect modulation of other factors of the host immune response, or enhanced recognition of P. murina by alveolar macrophages [23,23,72,76]. SP-A could also exert its protective effects by a combination of all these activities.
###end p 80
###begin p 81
###xml 0 13 0 13 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pneumocystis </italic>
###xml 223 236 223 236 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. jirovecii </italic>
###xml 366 368 366 368 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B77">77</xref>
###xml 473 485 473 485 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pneumocystis</italic>
###xml 184 192 <span type="species:ncbi:9606">patients</span>
###xml 223 235 <span type="species:ncbi:42068">P. jirovecii</span>
###xml 258 264 <span type="species:ncbi:9606">humans</span>
###xml 356 364 <span type="species:ncbi:9606">patients</span>
###xml 619 627 <span type="species:ncbi:9606">patients</span>
Pneumocystis colonization in immunocompetent hosts may be a mechanism that the organism uses as a survival and transmission strategy, thus is relevant to the care of immunocompromised patients. The detection of significant P. jirovecii colonization rates in humans suggests the need for caution in interactions between hospital staff and immunocompromised patients [77]. Identification of factors involved in protecting the immunocompetent host from becoming infected with Pneumocystis, may provide tools to eliminate this reservoir of infection and reduce spread of the disease to highly susceptible immunocompromised patients.
###end p 81
###begin p 82
###xml 40 50 40 50 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. murina </italic>
###xml 138 140 138 140 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B24">24</xref>
###xml 141 143 141 143 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B26">26</xref>
###xml 196 209 196 209 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. jirovecii </italic>
###xml 421 423 421 423 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B78">78</xref>
###xml 523 536 523 536 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. jirovecii </italic>
###xml 725 738 725 738 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pneumocystis </italic>
###xml 820 833 820 833 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. jirovecii </italic>
###xml 938 940 938 940 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B79">79</xref>
###xml 1090 1092 1090 1092 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B80">80</xref>
###xml 1239 1247 1239 1247 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. jirov</italic>
###xml 1363 1373 1363 1373 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. murina </italic>
###xml 1382 1384 1382 1384 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B81">81</xref>
###xml 1547 1549 1547 1549 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B82">82</xref>
###xml 1708 1710 1708 1710 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B83">83</xref>
###xml 1711 1713 1711 1713 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B84">84</xref>
###xml 1863 1876 1863 1876 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. jirovecii </italic>
###xml 40 49 <span type="species:ncbi:263815">P. murina</span>
###xml 93 95 <span type="species:ncbi:10090">KO</span>
###xml 96 101 <span type="species:ncbi:10090">mouse</span>
###xml 196 208 <span type="species:ncbi:42068">P. jirovecii</span>
###xml 222 228 <span type="species:ncbi:9606">humans</span>
###xml 315 318 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 523 535 <span type="species:ncbi:42068">P. jirovecii</span>
###xml 539 545 <span type="species:ncbi:9606">humans</span>
###xml 820 832 <span type="species:ncbi:42068">P. jirovecii</span>
###xml 849 855 <span type="species:ncbi:9606">humans</span>
###xml 946 952 <span type="species:ncbi:9606">humans</span>
###xml 1054 1061 <span type="species:ncbi:9606">persons</span>
###xml 1239 1251 <span type="species:ncbi:42068">P. jirovecii</span>
###xml 1363 1372 <span type="species:ncbi:263815">P. murina</span>
###xml 1376 1380 <span type="species:ncbi:10090">mice</span>
###xml 1475 1481 <span type="species:ncbi:9606">humans</span>
###xml 1863 1875 <span type="species:ncbi:42068">P. jirovecii</span>
###xml 1892 1898 <span type="species:ncbi:9606">humans</span>
A role for SP-A in host defense against P. murina infection has been clearly demonstrated in KO mouse models and by in vitro experiments [24,26]. However, the role of SP-A in the host response to P. jirovecii infection in humans has not yet been established. It has been shown that immunodeficient individuals with HIV/AIDS and PcP have increased levels of SP-A in BALF compared to individuals with bacterial pneumonias [78]. In that work, the authors did not demonstrate a functional role for SP-A in the host response to P. jirovecii in humans, but the results suggest that SP-A may be involved. The results presented in the current study indicate that SP-A may also be involved in protecting the immunocompetent host from Pneumocystis colonization. As described above, the pathophysiologic mechanisms associated with P. jirovecii colonization in humans, in addition to immunodeficiency, include chronic pulmonary diseases and smoking [79]. In humans, SP-A levels within BALF have been show to vary considerably among normal individuals and also among persons with various lung diseases [80]. It is interesting to note that SP-A levels have been shown to be decreased by smoking and smoking has also been identified as a risk factor for P. jirovecii colonization. Recent work has also demonstrated that exposure to cigarette smoke leads to increased burdens of P. murina in mice [81]. Two unique variants of SP-A (SP-A1 and SP-A2) are expressed from two different genes in humans and more than 30 alleles have been described for the SP-A genes [82]. It has been shown that the SP-A variants have functional differences and postulated that SP-A2 may be more active in the innate immune response than SP-A1 [83,84]. Based on these findings it is possible that decreased SP-A levels or expression of particular SP-A variants may lead to enhanced susceptibility to P. jirovecii colonization in humans.
###end p 82
###begin title 83
Conclusion
###end title 83
###begin p 84
###xml 102 112 102 112 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. murina </italic>
###xml 155 168 155 168 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pneumocystis </italic>
###xml 306 316 306 316 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. murina </italic>
###xml 102 111 <span type="species:ncbi:263815">P. murina</span>
###xml 220 226 <span type="species:ncbi:9606">humans</span>
###xml 284 288 <span type="species:ncbi:10090">mice</span>
###xml 306 315 <span type="species:ncbi:263815">P. murina</span>
The data in this study support an important role for SP-A in protecting the immunocompetent host from P. murina colonization, and provide a model to study Pneumocystis colonization acquired via environmental exposure in humans. The results also illustrate the difficulties in keeping mice from exposure to P. murina even when housed under barrier conditions.
###end p 84
###begin title 85
Abbreviations
###end title 85
###begin p 86
###xml 5 18 5 18 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pneumocystis </italic>
###xml 135 137 <span type="species:ncbi:10090">KO</span>
PcP: Pneumocystis pneumonia; UC: University of Cincinnati; LAM: Laboratory Animal Medicine; SP-A: surfactant protein A; WT: wild type; KO-SP-A: knockout; qPCR: reverse-transcriptase quantitative PCR; ELISA: enzyme-linked immunosorbent assay; mtLSU: large mitochondrial ribosomal RNA gene; SCID: severe combined immunodeficiency.
###end p 86
###begin title 87
Competing interests
###end title 87
###begin p 88
None of the authors has a commercial or other association that might pose a conflict of interest.
###end p 88
###begin title 89
Authors' contributions
###end title 89
###begin p 90
MJL led he design and supervision of the experiments, data analysis, and preparation of the manuscript. ADA carried out the animal studies and ELISA. JAD carried out the molecular studies. PDW provide overall leadership to the design of the experiments, data analysis, and preparation of the manuscript.
###end p 90
###begin title 91
Acknowledgements
###end title 91
###begin p 92
This work was supported by the Medical Research Service, Department of Veterans Affairs, and by the Public Service contract AI 75319 and grant RO1 HL64570 from the National Institutes of Health (PDW).
###end p 92
###begin article-title 93
###xml 0 36 0 36 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pneumocystis carinii f. sp. hominis </italic>
###xml 0 35 <span type="species:ncbi:42068">Pneumocystis carinii f. sp. hominis</span>
###xml 63 67 <span type="species:ncbi:10090">mice</span>
Pneumocystis carinii f. sp. hominis is not infectious for SCID mice
###end article-title 93
###begin article-title 94
###xml 89 110 89 110 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pneumocystis carinii </italic>
###xml 74 77 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 89 109 <span type="species:ncbi:4754">Pneumocystis carinii</span>
A new preadmission staging system for predicting inpatient mortality from HIV-associated Pneumocystis carinii pneumonia in the early highly active antiretroviral therapy (HAART) era
###end article-title 94
###begin article-title 95
###xml 0 22 0 22 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pneumocystis jiroveci </italic>
###xml 0 21 <span type="species:ncbi:42068">Pneumocystis jiroveci</span>
###xml 59 67 <span type="species:ncbi:9606">patients</span>
###xml 99 107 <span type="species:ncbi:9606">patients</span>
Pneumocystis jiroveci internal transcribed spacer types in patients colonized by the fungus and in patients with pneumocystosis from the same French geographic region
###end article-title 95
###begin article-title 96
###xml 23 36 23 36 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pneumocystis </italic>
###xml 76 83 <span type="species:ncbi:9606">Infants</span>
Genetic Differences in Pneumocystis Isolates Recovered from Immunocompetent Infants and from Adults with AIDS: Epidemiological Implications
###end article-title 96
###begin article-title 97
###xml 82 95 82 95 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pneumocystis </italic>
###xml 124 128 <span type="species:ncbi:10090">mice</span>
Quantitative real-time polymerase chain-reaction assay allows characterization of Pneumocystis infection in immunocompetent mice
###end article-title 97
###begin article-title 98
###xml 42 63 42 63 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pneumocystis carinii </italic>
###xml 42 62 <span type="species:ncbi:4754">Pneumocystis carinii</span>
Effect of oral washes on the diagnosis of Pneumocystis carinii pneumonia with a low parasite burden and on detection of organisms in subclinical infections
###end article-title 98
###begin article-title 99
###xml 38 51 38 51 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pneumocystis </italic>
###xml 70 73 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 83 86 <span type="species:ncbi:9606">men</span>
Prevalence and clinical predictors of Pneumocystis colonization among HIV-infected men
###end article-title 99
###begin article-title 100
###xml 33 55 33 55 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pneumocystis jiroveci </italic>
###xml 33 54 <span type="species:ncbi:42068">Pneumocystis jiroveci</span>
###xml 58 86 <span type="species:ncbi:12721">human immunodeficiency virus</span>
###xml 96 104 <span type="species:ncbi:9606">patients</span>
Limited asymptomatic carriage of Pneumocystis jiroveci in human immunodeficiency virus-infected patients
###end article-title 100
###begin article-title 101
###xml 93 114 93 114 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pneumocystis carinii </italic>
###xml 93 113 <span type="species:ncbi:4754">Pneumocystis carinii</span>
Development and evaluation of a quantitative, touch-down, real-time PCR assay for diagnosing Pneumocystis carinii pneumonia
###end article-title 101
###begin article-title 102
Pneumocystis colonization, airway inflammation, and pulmonary function decline in acquired immunodeficiency syndrome
###end article-title 102
###begin article-title 103
Association of chronic obstructive pulmonary disease severity and Pneumocystis colonization
###end article-title 103
###begin article-title 104
###xml 25 33 <span type="species:ncbi:9606">patients</span>
###xml 100 121 <span type="species:ncbi:42068">Pneumocystis jiroveci</span>
Systemic inflammation in patients with chronic obstructive pulmonary disease who are colonized with Pneumocystis jiroveci
###end article-title 104
###begin article-title 105
###xml 0 21 <span type="species:ncbi:42068">Pneumocystis jiroveci</span>
###xml 74 82 <span type="species:ncbi:9606">patients</span>
Pneumocystis jiroveci isolates with dihydropteroate synthase mutations in patients with chronic bronchitis
###end article-title 105
###begin article-title 106
###xml 65 86 65 86 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pneumocystis carinii </italic>
###xml 37 41 <span type="species:ncbi:10090">mice</span>
###xml 65 85 <span type="species:ncbi:4754">Pneumocystis carinii</span>
Immunodeficient and immunosuppressed mice as models to test anti-Pneumocystis carinii drugs
###end article-title 106
###begin article-title 107
The pulmonary collectins, SP-A and SP-D, orchestrate innate immunity in the lung
###end article-title 107
###begin article-title 108
###xml 64 68 <span type="species:ncbi:10090">mice</span>
Altered surfactant function and structure in SP-A gene targeted mice
###end article-title 108
###begin article-title 109
Pulmonary collectins and innate host defense of the lung
###end article-title 109
###begin article-title 110
###xml 114 134 114 134 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pneumocystis carinii</italic>
###xml 114 134 <span type="species:ncbi:4754">Pneumocystis carinii</span>
The carbohydrate recognition domain of surfactant protein A mediates binding to the major surface glycoprotein of Pneumocystis carinii
###end article-title 110
###begin article-title 111
###xml 65 92 65 92 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mycobacterium tuberculosis </italic>
###xml 65 91 <span type="species:ncbi:1773">Mycobacterium tuberculosis</span>
###xml 121 126 <span type="species:ncbi:9606">human</span>
Pulmonary surfactant protein A mediates enhanced phagocytosis of Mycobacterium tuberculosis by a direct interaction with human macrophages
###end article-title 111
###begin article-title 112
Lung surfactant and reactive oxygen-nitrogen species: antimicrobial activity and host-pathogen interactions
###end article-title 112
###begin article-title 113
Surfactant protein A modulates release of reactive oxygen species from alveolar macrophages
###end article-title 113
###begin article-title 114
Pulmonary surfactant protein A stimulates chemotaxis of alveolar macrophage
###end article-title 114
###begin article-title 115
Macrophage-independent fungicidal action of the pulmonary collectins
###end article-title 115
###begin article-title 116
###xml 86 107 86 107 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pneumocystis carinii </italic>
###xml 48 52 <span type="species:ncbi:10090">mice</span>
###xml 86 106 <span type="species:ncbi:4754">Pneumocystis carinii</span>
Immunosuppressed surfactant protein A-deficient mice have increased susceptibility to Pneumocystis carinii infection
###end article-title 116
###begin article-title 117
###xml 28 48 28 48 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pneumocystis murina </italic>
###xml 28 47 <span type="species:ncbi:263815">Pneumocystis murina</span>
###xml 86 90 <span type="species:ncbi:10090">mice</span>
Surfactant protein A limits Pneumocystis murina infection in immunosuppressed C3H/HeN mice and modulates host response during infection
###end article-title 117
###begin article-title 118
###xml 46 67 46 67 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pneumocystis carinii </italic>
###xml 46 66 <span type="species:ncbi:4754">Pneumocystis carinii</span>
###xml 101 105 <span type="species:ncbi:10090">mice</span>
Enhanced lung injury and delayed clearance of Pneumocystis carinii in surfactant protein A-deficient mice: attenuation of cytokine responses and reactive oxygen-nitrogen species
###end article-title 118
###begin article-title 119
###xml 42 46 <span type="species:ncbi:10090">mice</span>
Surfactant protein A (SP-A) gene targeted mice
###end article-title 119
###begin article-title 120
Surfactant proteins A and D inhibit the growth of Gram-negative bacteria by increasing membrane permeability
###end article-title 120
###begin article-title 121
###xml 15 35 <span type="species:ncbi:4754">Pneumocystis carinii</span>
###xml 49 53 <span type="species:ncbi:10090">mice</span>
A new model of Pneumocystis carinii infection in mice selectively depleted of helper T lymphocytes
###end article-title 121
###begin article-title 122
###xml 17 38 17 38 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pneumocystis carinii </italic>
###xml 17 37 <span type="species:ncbi:4754">Pneumocystis carinii</span>
###xml 49 54 <span type="species:ncbi:10090">mouse</span>
Establishment of Pneumocystis carinii in various mouse strains using natural transmission to initiate infection
###end article-title 122
###begin article-title 123
###xml 11 16 <span type="species:ncbi:10090">mouse</span>
###xml 26 46 <span type="species:ncbi:4754">Pneumocystis carinii</span>
Inoculated mouse model of Pneumocystis carinii infection
###end article-title 123
###begin article-title 124
###xml 89 110 89 110 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pneumocystis carinii </italic>
###xml 82 88 <span type="species:ncbi:10090">murine</span>
###xml 89 109 <span type="species:ncbi:4754">Pneumocystis carinii</span>
Local delivery of the viral interleukin-10 gene suppresses tissue inflammation in murine Pneumocystis carinii infection
###end article-title 124
###begin article-title 125
###xml 40 74 40 74 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pneumocystis carinii f. sp. muris </italic>
###xml 40 73 <span type="species:ncbi:263815">Pneumocystis carinii f. sp. muris</span>
Alveolar macrophage-mediated killing of Pneumocystis carinii f. sp. muris involves molecular recognition by the Dectin-1 beta-glucan receptor
###end article-title 125
###begin article-title 126
###xml 14 34 14 34 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pneumocystis murina </italic>
###xml 14 33 <span type="species:ncbi:263815">Pneumocystis murina</span>
Resolution of Pneumocystis murina infection following withdrawal of corticosteroid induced immunosuppression
###end article-title 126
###begin article-title 127
###xml 17 30 17 30 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pneumocystis </italic>
###xml 4 7 <span type="species:ncbi:10116">rat</span>
New rat model of Pneumocystis pneumonia induced by anti-CD4(+) T-lymphocyte antibodies
###end article-title 127
###begin article-title 128
###xml 13 34 13 34 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pneumocystis carinii </italic>
###xml 13 33 <span type="species:ncbi:4754">Pneumocystis carinii</span>
###xml 95 102 <span type="species:ncbi:9606">persons</span>
Detection of Pneumocystis carinii DNA in air samples: likely environmental risk to susceptible persons
###end article-title 128
###begin article-title 129
###xml 13 34 13 34 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pneumocystis carinii </italic>
###xml 13 33 <span type="species:ncbi:4754">Pneumocystis carinii</span>
Detection of Pneumocystis carinii DNA by filtration of air
###end article-title 129
###begin article-title 130
###xml 27 63 27 63 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pneumocystis carinii f. sp. carinii </italic>
###xml 67 103 67 103 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pneumocystis carinii f. sp. hominis </italic>
###xml 27 62 <span type="species:ncbi:4754">Pneumocystis carinii f. sp. carinii</span>
###xml 67 102 <span type="species:ncbi:42068">Pneumocystis carinii f. sp. hominis</span>
DNA sequences identical to Pneumocystis carinii f. sp. carinii and Pneumocystis carinii f. sp. hominis in samples of air spora
###end article-title 130
###begin article-title 131
###xml 124 145 124 145 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pneumocystis carinii </italic>
###xml 124 144 <span type="species:ncbi:4754">Pneumocystis carinii</span>
Magnetic bead capture eliminates PCR inhibitors in samples collected from the airborne environment, permitting detection of Pneumocystis carinii DNA
###end article-title 131
###begin article-title 132
###xml 16 36 <span type="species:ncbi:4754">Pneumocystis carinii</span>
###xml 48 55 <span type="species:ncbi:9606">patient</span>
###xml 61 71 <span type="species:ncbi:4754">P. carinii</span>
Transmission of Pneumocystis carinii DNA from a patient with P. carinii pneumonia to immunocompetent contact health care workers
###end article-title 132
###begin article-title 133
###xml 16 37 16 37 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pneumocystis carinii </italic>
###xml 105 126 105 126 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pneumocystis carinii </italic>
###xml 16 36 <span type="species:ncbi:4754">Pneumocystis carinii</span>
###xml 47 55 <span type="species:ncbi:9606">patients</span>
###xml 82 90 <span type="species:ncbi:9606">patients</span>
###xml 105 125 <span type="species:ncbi:4754">Pneumocystis carinii</span>
Transmission of Pneumocystis carinii from AIDS patients to other immunosuppressed patients: a cluster of Pneumocystis carinii pneumonia in renal transplant recipients
###end article-title 133
###begin article-title 134
###xml 49 62 49 62 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pneumocystis </italic>
###xml 124 127 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 137 145 <span type="species:ncbi:9606">patients</span>
Molecular evidence of interhuman transmission of Pneumocystis pneumonia among renal transplant recipients hospitalized with HIV-infected patients
###end article-title 134
###begin article-title 135
###xml 9 30 9 30 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pneumocystis carinii </italic>
###xml 9 29 <span type="species:ncbi:4754">Pneumocystis carinii</span>
###xml 49 57 <span type="species:ncbi:9606">patients</span>
Risk for Pneumocystis carinii transmission among patients with pneumonia: a molecular epidemiology study
###end article-title 135
###begin article-title 136
###xml 71 92 71 92 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pneumocystis carinii </italic>
###xml 12 18 <span type="species:ncbi:9606">person</span>
###xml 22 28 <span type="species:ncbi:9606">person</span>
###xml 71 91 <span type="species:ncbi:4754">Pneumocystis carinii</span>
The role of person-to-person transmission in an epidemiologic study of Pneumocystis carinii pneumonia
###end article-title 136
###begin article-title 137
###xml 10 31 10 31 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pneumocystis carinii </italic>
###xml 10 30 <span type="species:ncbi:4754">Pneumocystis carinii</span>
###xml 74 82 <span type="species:ncbi:9606">patients</span>
Source of Pneumocystis carinii in recurrent episodes of pneumonia in AIDS patients
###end article-title 137
###begin article-title 138
###xml 78 107 78 107 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pneumocystis carinii hominis </italic>
###xml 78 106 <span type="species:ncbi:42068">Pneumocystis carinii hominis</span>
###xml 156 184 <span type="species:ncbi:12721">human immunodeficiency virus</span>
###xml 194 202 <span type="species:ncbi:9606">patients</span>
Study of internal transcribed spacer and mitochondrial large-subunit genes of Pneumocystis carinii hominis isolated by repeated bronchoalveolar lavage from human immunodeficiency virus-infected patients during one or several episodes of pneumonia
###end article-title 138
###begin article-title 139
###xml 60 80 <span type="species:ncbi:4754">Pneumocystis carinii</span>
###xml 88 91 <span type="species:ncbi:10116">rat</span>
###xml 96 101 <span type="species:ncbi:9606">human</span>
Amplification of mitochondrial ribosomal RNA sequences from Pneumocystis carinii DNA of rat and human origin
###end article-title 139
###begin article-title 140
###xml 13 33 <span type="species:ncbi:4754">Pneumocystis carinii</span>
A search for Pneumocystis carinii in post-mortem lungs by DNA amplification
###end article-title 140
###begin article-title 141
###xml 74 94 <span type="species:ncbi:4754">Pneumocystis carinii</span>
###xml 111 114 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 128 131 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
DNA amplification by the polymerase chain reaction to detect sub-clinical Pneumocystis carinii colonization in HIV-positive and HIV-negative male homosexuals with and without respiratory symptoms
###end article-title 141
###begin article-title 142
###xml 13 33 <span type="species:ncbi:4754">Pneumocystis carinii</span>
Detection of Pneumocystis carinii with DNA amplification
###end article-title 142
###begin article-title 143
###xml 20 43 20 43 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pneumocystis jirovecii </italic>
###xml 20 42 <span type="species:ncbi:42068">Pneumocystis jirovecii</span>
Apparent absence of Pneumocystis jirovecii in healthy subjects
###end article-title 143
###begin article-title 144
###xml 32 52 <span type="species:ncbi:4754">Pneumocystis carinii</span>
###xml 69 72 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 86 89 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 99 107 <span type="species:ncbi:9606">patients</span>
Pneumocystosis versus pulmonary Pneumocystis carinii colonization in HIV-negative and HIV-positive patients
###end article-title 144
###begin article-title 145
###xml 55 58 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 68 76 <span type="species:ncbi:9606">patients</span>
Pneumocystis colonisation is common among hospitalised HIV infected patients with non-Pneumocystis pneumonia
###end article-title 145
###begin article-title 146
###xml 0 20 <span type="species:ncbi:4754">Pneumocystis carinii</span>
###xml 49 57 <span type="species:ncbi:9606">patients</span>
Pneumocystis carinii carriage in immunocompetent patients with primary pulmonary disorders as detected by single or nested PCR
###end article-title 146
###begin article-title 147
###xml 11 31 <span type="species:ncbi:4754">Pneumocystis carinii</span>
###xml 47 55 <span type="species:ncbi:9606">patients</span>
Absence of Pneumocystis carinii carriers among patients with cystic fibrosis
###end article-title 147
###begin article-title 148
###xml 0 20 <span type="species:ncbi:4754">Pneumocystis carinii</span>
###xml 52 60 <span type="species:ncbi:9606">patients</span>
Pneumocystis carinii carriage among cystic fibrosis patients, as detected by nested PCR
###end article-title 148
###begin article-title 149
###xml 61 83 <span type="species:ncbi:42068">Pneumocystis jirovecii</span>
###xml 106 114 <span type="species:ncbi:9606">patients</span>
Prevalence of colonisation and genotypic characterisation of Pneumocystis jirovecii among cystic fibrosis patients in Spain
###end article-title 149
###begin article-title 150
###xml 34 56 <span type="species:ncbi:42068">Pneumocystis jirovecii</span>
###xml 86 94 <span type="species:ncbi:9606">patients</span>
Dynamic colonisation by different Pneumocystis jirovecii genotypes in cystic fibrosis patients
###end article-title 150
###begin article-title 151
###xml 0 20 <span type="species:ncbi:4754">Pneumocystis carinii</span>
###xml 34 42 <span type="species:ncbi:9606">patients</span>
Pneumocystis carinii infection in patients with chronic bronchial disease
###end article-title 151
###begin article-title 152
###xml 40 53 40 53 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pneumocystis </italic>
Immunocompetent hosts as a reservoir of Pneumocystis organisms: histological and rt-PCR data demonstrate active replication
###end article-title 152
###begin article-title 153
###xml 42 76 42 76 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pneumocystis carinii f. sp. muris </italic>
###xml 100 124 100 124 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P. carinii f. sp. muris </italic>
###xml 34 38 <span type="species:ncbi:10090">mice</span>
###xml 42 75 <span type="species:ncbi:263815">Pneumocystis carinii f. sp. muris</span>
###xml 100 123 <span type="species:ncbi:263815">P. carinii f. sp. muris</span>
Exposure of immunocompetent adult mice to Pneumocystis carinii f. sp. muris by cohousing: growth of P. carinii f. sp. muris and host immune reresponse
###end article-title 153
###begin article-title 154
###xml 36 70 36 70 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pneumocystis carinii f. sp. muris </italic>
###xml 36 69 <span type="species:ncbi:263815">Pneumocystis carinii f. sp. muris</span>
###xml 101 105 <span type="species:ncbi:10090">mice</span>
Characterization of transmission of Pneumocystis carinii f. sp. muris through immunocompetent BALB/c mice
###end article-title 154
###begin article-title 155
An evaluation of intra-cage ventilation in three animal caging systems
###end article-title 155
###begin article-title 156
###xml 25 46 25 46 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pneumocystis carinii </italic>
###xml 25 45 <span type="species:ncbi:4754">Pneumocystis carinii</span>
###xml 60 63 <span type="species:ncbi:10116">rat</span>
Widespread occurrence of Pneumocystis carinii in commercial rat colonies detected using targeted PCR and oral swabs
###end article-title 156
###begin article-title 157
###xml 13 34 13 34 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pneumocystis carinii </italic>
###xml 13 33 <span type="species:ncbi:4754">Pneumocystis carinii</span>
###xml 75 79 <span type="species:ncbi:10090">mice</span>
Outbreaks of Pneumocystis carinii pneumonia in colonies of immunodeficient mice
###end article-title 157
###begin article-title 158
###xml 68 72 <span type="species:ncbi:10090">mice</span>
Assessing the risk of transmission of three infectious agents among mice housed in a negatively pressurized caging system
###end article-title 158
###begin article-title 159
###xml 0 21 0 21 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pneumocystis carinii </italic>
###xml 0 20 <span type="species:ncbi:4754">Pneumocystis carinii</span>
###xml 41 45 <span type="species:ncbi:10090">mice</span>
Pneumocystis carinii pneumonia in mutant mice deficient in both TCRalpha/beta and TCRgamma/delta cells: cytokine and antibody responses
###end article-title 159
###begin article-title 160
###xml 79 83 <span type="species:ncbi:10090">mice</span>
Surfactant associated protein-A provides critical immunoprotection in neonatal mice
###end article-title 160
###begin article-title 161
###xml 21 42 21 42 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pneumocystis carinii </italic>
###xml 21 41 <span type="species:ncbi:4754">Pneumocystis carinii</span>
###xml 155 159 <span type="species:ncbi:10090">mice</span>
Delayed clearance of Pneumocystis carinii infection, increased inflammation, and altered nitric oxide metabolism in lungs of surfactant protein-D knockout mice
###end article-title 161
###begin article-title 162
Surfactant protein A and surfactant protein D in health and disease
###end article-title 162
###begin article-title 163
###xml 57 78 57 78 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pneumocystis carinii </italic>
###xml 57 77 <span type="species:ncbi:4754">Pneumocystis carinii</span>
###xml 81 86 <span type="species:ncbi:9606">human</span>
Surfactant protein-A reduces binding and phagocytosis of Pneumocystis carinii by human alveolar macrophages in vitro
###end article-title 163
###begin article-title 164
###xml 50 71 50 71 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pneumocystis carinii </italic>
###xml 0 5 <span type="species:ncbi:9606">Human</span>
###xml 50 70 <span type="species:ncbi:4754">Pneumocystis carinii</span>
###xml 74 77 <span type="species:ncbi:10116">rat</span>
Human surfactant protein A enhances attachment of Pneumocystis carinii to rat alveolar macrophages
###end article-title 164
###begin article-title 165
###xml 54 60 <span type="species:ncbi:10090">murine</span>
Surfactant protein A modulates the differentiation of murine bone marrow-derived dendritic cells
###end article-title 165
###begin article-title 166
Surfactant protein D enhances bacterial antigen presentation by bone marrow-derived dendritic cells
###end article-title 166
###begin article-title 167
Surfactant protein A binds to IgG and enhances phagocytosis of IgG-opsonized erythrocytes
###end article-title 167
###begin article-title 168
###xml 122 127 <span type="species:ncbi:9606">human</span>
Pulmonary surfactant protein A up-regulates activity of the mannose receptor, a pattern recognition receptor expressed on human macrophages
###end article-title 168
###begin article-title 169
###xml 16 37 16 37 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pneumocystis carinii </italic>
###xml 16 36 <span type="species:ncbi:4754">Pneumocystis carinii</span>
###xml 42 50 <span type="species:ncbi:9606">patients</span>
Transmission of Pneumocystis carinii from patients to hospital staff
###end article-title 169
###begin article-title 170
###xml 0 21 0 21 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pneumocystis carinii </italic>
###xml 0 20 <span type="species:ncbi:4754">Pneumocystis carinii</span>
Pneumocystis carinii alters surfactant protein A concentrations in bronchoalveolar lavage fluid
###end article-title 170
###begin article-title 171
Epidemiology and clinical significance of pneumocystis colonization
###end article-title 171
###begin article-title 172
###xml 22 27 <span type="species:ncbi:9606">human</span>
Characterization of a human surfactant protein A1 (SP-A1) gene-specific antibody; SP-A1 content variation among individuals of varying age and pulmonary health
###end article-title 172
###begin article-title 173
###xml 0 19 <span type="species:ncbi:263815">Pneumocystis murina</span>
###xml 171 175 <span type="species:ncbi:10090">mice</span>
Pneumocystis murina infection and cigarette smoke exposure interact to cause increased organism burden, development of airspace enlargement, and pulmonary inflammation in mice
###end article-title 173
###begin article-title 174
Surfactant protein A and surfactant protein D variation in pulmonary disease
###end article-title 174
###begin article-title 175
###xml 63 85 <span type="species:ncbi:287">Pseudomonas aeruginosa</span>
###xml 91 94 <span type="species:ncbi:10116">rat</span>
SP-A1 and SP-A2 variants differentially enhance association of Pseudomonas aeruginosa with rat alveolar macrophages
###end article-title 175
###begin article-title 176
###xml 73 78 <span type="species:ncbi:9606">human</span>
Differences in biochemical properties and in biological function between human SP-A1 and SP-A2 variants, and the impact of ozone-induced oxidation
###end article-title 176

